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1. Introduction 
 1.1 The cell cycle  
The cell cycle is an ordered set of events eventually culminating in cell 
growth and division into two daughter cells. In virtually in all cells, the cell cycle 
is composed of four discrete phases, which are the DNA synthesis phase (S 
phase), the mitotic phase (M phase) 
During the last decades, a wealth of knowledge has become available 
giving insight into the molecular mechanisms controlling cell cycle regulation. 
and the intermediate gap phases referred 
to as G1-phase (between M and S phases) and G2-phase (between S and M 
phases).  
Cyclins and their partners, the cyclin dependent kinases (CDKs)
 
 constitute 
the basis of these molecular mechanisms (Boonstra, 2003). 
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In primitive eukaryotes such as yeast only one Cdk molecule is able to regulate 
all phases of the cell cycle by interaction with different cyclins. In mammals 
(Fig.1) each phase of the cell cycle (G1, S, G2, M) is characterized by its own 
set of Cdks and cyclins which were thought to be essential for this process 
(Kaldis and Aleem, 2005). 
The most important mammalian cyclin-CDK complexes known so far are, 
the G1-cyclins D and E in complex with CDK 4/6 and CDK2, respectively 
Fig. 1 Overview of the cell 
cycle in mammalian cells. 
 
As cells proceed through the 
cycle, four major cyclins are 
produced sequentially (D, E, A, 
and B), and activate different 
CDKs.  After progression 
through the restriction point 
(R) cells enter the S-phase, 
where DNA synthesis and 
replication occur. If cells are 
not ready or conditions are not 
appropriate, they enter G0 
phase, a quiescent stage.  
 
1. Introduction                                                                                                    2 
(compare Fig.1), and the mitotic cyclins A and B which are associated with 
CDK1 (Nigg, 1995; Sherr, 1995).  
 
1.1.1 Cyclin D as an regulatory protein  
The decision of a normal cell to replicate DNA and duplicate itself is 
influenced by extracellular signals such as cytokines and growth factors. Growth 
factors are necessary to initiate and maintain the transition through G1 phase 
eventually leading to DNA synthesis. The point in G1 at which commitment 
occurs and the cell no longer requires growth factors to complete the cell cycle 
has been termed “restriction point” (compare Fig.1). Transition of the restriction 
point was proposed to be determined by accumulation of a functionally short-
lived (labile) regulatory protein (R-protein) such as cyclin D, whose synthesis is 
regulated by growth factors and accumulates to a critical amount before a cell 
can pass the restriction point and proceed towards DNA synthesis. 
D-type cyclins represent a very unique component of the cell cycle 
apparatus. Unlike other cyclins that are periodically induced during the cell cycle 
progression, the level of D-cyclins is controlled by the extracellular mitogen 
environment. For this reason, D-cyclins are believed to serve as “links” between 
the extracellular environment and core cell cycle machinery (Kozar and Sicinski, 
2005). Growth factors regulate cyclin D1 by at least four mechanisms: 
1. transcriptional induction 
2. stabilization of the protein 
3. translocation to the nucleus 
4. assembly with its catalytic partners, CDK 4 and CDK 6. 
After complex formation with CDK4 and CDK6 and subsequent nuclear 
translocation the active cyclin D/CDK kinase complex phoshorylates especially 
retinoblastoma (Rb) proteins (Hinds et al., 1992). 
The retinoblastoma family includes three members, Rb/p105, p107 and 
Rb2/p130, respectively, which are collectively referred to as ‘pocket proteins’. 
The unphosphorylated Rb proteins repress gene transcription by binding and 
thereby inhibiting E2F transcription factors. Phosphorylation of Rb is required 
for transition from G1 to S phase as it prevents its binding to E2F, thus 
activating E2F-mediated gene transcription and also relieving transcriptional 
repression(Giacinti and Giordano, 2006). Consequently activation of E2F in G1 
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allows the transcription of genes required for cell cycle progression (Grana et 
al., 1998) (Fig.2). 
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1.1.3 Cyclin E as a „Master Cyclin“  
In contrast to growth factor inducible D type cyclins, the expression of E-
type cyclins is controlled by an autonomous mechanism and peaks sharply at 
G1/S border (Koff et al., 1992). After passing the restriction point, the cell cycle 
becomes substantially less responsive to extracellular factors, which can delay 
entry into the S-phase or even arrest the cell cycle. The regulation of the cell 
cycle progression through the restriction point is believed to be the main 
function of the E-cyclins.  E-type cyclins complete phosphorylation of pRB 
(compare Fig 3), which was initiated by the action of cyclin D-CDK complexes. 
Since cyclin E/cdk2 complexes themselves also phosphorylate pocket proteins 
such as Rb and its relatives p130 and p107, the concentration of released E2F 
increases leading to further amplification of cyclin E transcription. Moreover, 
cyclin E/cdk2 complexes can phosphorylate E2F and thereby modulate its 
activity. This constitutes a classical feedback mechanism, conferring cyclin E 
the ability to stimulate its own transcription (Moroy and Geisen, 2004). 
 
Fig. 2: The restriction knot (simplified scheme).  
 
Cyclin D-CDK4/6 phosphorylate Rb, thus activating E2Fmediated transcription and 
also relieving transcriptional repression.E2F-1 transactivates cyclins E and A. Cyclin 
E enters into a complex with CDK2 and collaborates with cyclin D-CDKs to complete 
Rb phosphorylation. This shift from cyclin D-CDK 4 to cyclin E-CDK2 accounts for the 
loss of dependency on growth factors. Given numerous positive and negative 
feedback loops, the restriction point is in fact a restriction knot (adopted from 
(Blagosklonny and Pardee, 2002; Saile and Ramadori, 2007). 
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Aside from this specific function as a regulator of S-phase-entry, cyclin E 
plays a direct role in the initiation of DNA replication, the control of genomic 
stability, and the centrosome cycle (Moroy and Geisen, 2004). 
Repression of the cyclin E gene during G2-M and the early G1 phase of 
the cell cycle is mediated through the assembly of a multiprotein-complex, 
containing hypophosphorylated pRB, Histone deacetylase (HDAC), and 
chromatin remodeling factors of the SWI/SNF family, which are recruited to E2F 
transcription factors bound to the cyclin E promoter in order to silence cyclin E 
gene transcription. 
The regular cyclin E protein contains a so-called “cyclin-box” which is a 
domain stretching from amino acid position 129-215 and is conserved to a 
certain degree among many cyclins. The cyclin-box domain is a structural motif 
required for cyclin–CDK complex formation. The C-terminal domains of cyclin E 
contain a conserved TPP motif. CDK2-mediated phosphorylation of this site 
leads to the dissociation of the complex and targets ubiquitin-mediated 
proteolysis  (Moroy and Geisen, 2004). 
 
 
 
Fig. 3: “R-factor.”  
 
Both D-type cyclins and cyclin E 
meet some criteria of restriction 
factors. Phosphorylation of Rb is 
initiated by CDK4/6-cyclin D, but is 
completed by CDK2-cyclin E. 
(adopted from (Blagosklonny and 
Pardee, 2002) 
 
Fig. 4: Alignment of the cyclin E1 and E2 cyclin-box domain. 
 
The highlighted region indicates conserved amino acid residues necessary for 
interaction with CDKs 
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Recently, three research groups independently discovered a second cyclin 
E family member, cyclin E2 (Gudas et al., 1999; Lauper et al., 1998; Zariwala et 
al., 1998). The methods of discovery included a homology search using a cyclin 
box domain to query an expressed sequence tag (EST) database, and a yeast 
two-hybrid screen using either human p27Kip1 or a catalytically inactive mutant 
of CDK2 as bait. Both cyclins show significant amino acid similarity (75% within 
the cyclin box, 47% throughout the entire coding sequence (Fig.4). Despite 
these similarities, it is still unknown whether the two proteins perform similar 
functions, or alternatively, control S-phase entry in different ways (Payton and 
Coats, 2002). 
 
1.1.4 The role of Cyclin A and B as “mitotic cyclins” 
Among the cyclin family, cyclin A
Entry into mitosis in eukaryotic cells is controlled by activation of the 
Serin/Threonin kinase cdc2 which interacts with one of several 
 is especially interesting as it can activate 
two different cyclin dependent kinases (CDK2 and CDK1/CDC2) and function in 
both S-phase and mitosis. An embryonic form of cyclin A that is only essential 
for spermatogenesis is also present in some organisms. In S-phase, 
phosphorylation of components of the DNA replication machinery such as 
CDC6 by cyclin A-CDK2 is believed to be important for initiation of DNA 
replication and to restrict the replication to only one per cell cycle. In mitosis, the 
precise role of cyclin A is still obscure, but it may contribute to the control of 
cyclin B stability (Pagano et al., 1992). Cyclin A starts to accumulate during S 
phase and is abruptly degraded before metaphase. The synthesis of cyclin A is 
mainly controlled at the transcription level, involving E2F and other transcription 
factors. Consistent with its role as a key cell cycle regulator, expression of cyclin 
A is found to be elevated in a variety of tumors (Yam et al., 2002). 
B-type cyclins
Protein levels of cyclin B begin to accumulate in late S-phase, peak at the 
G2/M transition, and decline considerably by the onset of anaphase. The 
temporal accumulation of cyclin B is required for cells to progress through the 
G2/M transition and degradation of the protein is a necessary step in cellular 
exit from mitosis. Spatially, cyclin B translocates into the nucleus in a 
phosphorylation-dependent manner. Once the activated cyclin B/cdc2 complex 
moves into the nucleus, it can phosphorylate a variety of substrates, including 
. 
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histone H1, microtubule-associated proteins (MAPs), nuclear lamins, and 
centrosomal proteins. These nuclear phosphorylation events regulate the 
initiation and progression of mitosis (Porter and Donoghue, 2003). 
At mitotic entry, cyclin B1/cdc2 promotes chromosome condensation, nuclear 
lamina resolution and mitotic spindle assembly, while cyclin B2/cdc2 can induce 
Golgi disassembly (Yu and Yao, 2008). 
 
1.1.5 Living with or without cyclins and cyclin-dependent kinases 
Entry into and progression through the mammalian cell cycle in response 
to extracellular mitogenic stimuli are presumed to be governed by cyclin-
dependent kinases which are regulated by different cyclins. Studies performed 
over more than one decade have supported the view that these holoenzymes 
are important, if not essential, for these processes. However, recent 
experiments, in which the genes encoding all three D-type cyclins, the two E-
type cyclins, cyclin D dependent kinases CDK4 and CDK6, or cyclin E-
dependent kinase CDK2 have been disrupted in the mouse germ line revealed 
that most of fetal development occurs normally in their absence. Thus, none of 
these genes is strictly essential for cell cycle progression (Sherr and Roberts, 
2004). The recent findings based on in vivo gene inactivation studies of cyclins 
and cyclin-dependent kinases are summarized in tables 1 and 2, respectively. 
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Disrupted 
gene 
Survival Phenotype 
Cyclin D1 viable 
Small body size, hypoplastic retinopathy, defective beast lobuloalveolar 
development during pregnancy, and uncharacterized neuropathy with 
altered clasping reflexes (Fantl et al., 1995; Sicinski et al., 1995) 
Cyclin D2 viable 
Defective ovarian granulosa cell development and female sterility. Males 
have hypoplastic testes but are fertile. Abnormal postnatal cerebellar 
development due to a reduced number of granule neurons and loss of 
stellate interneurons. Impaired proliferation of peripheral B-lymphocytes 
(Lam et al., 2000; Sicinski et al., 1996; Solvason et al., 2000) 
Cyclin D3 viable 
Hypoplastic thymus with loss of T-cell maturation from double-negative 
(CD4−, CD8−) to double-positive (CD4+,CD8+) cells due to cytokine-
independent defects in pre-TCR signaling (Geng et al., 2003) 
 
Cyclin D2 
and D3 
Embryonic 
lethality 
before E18.5 
 
Death likely is due to severe megaloblastic anemia. Other hematopoietic 
lineages were not evaluated (Ciemerych et al., 2002). 
 
Cyclin D1 
and D3 
Death at P1, 
but a few 
survive up to 
2 months 
 
Neuropathy leading to meconium aspiration is cause of early death. 
Survivors fail to thrive and exhibit hypoplastic retinas (Ciemerych et al., 
2002). 
 
 
Cyclin D1 
and D2 
Viable but die 
within 
first three 
postnatal 
weeks 
Retarded growth and impaired coordination. Inhibited postnatal cerebellar 
development, and hypoplastic retinas (Ciemerych et al., 2002). 
 
 
 
Cyclins D1, 
D2, and D3 
 
Dead by 
E16.5 
 
Severe hematopoietic deficits affecting number and proliferative capacity of 
stem cells and multipotential progenitors. Fetal liver lacks progenitors and 
cannot reconstitute lymphoid or myeloid function after transplantation. 
Death due to anemia and defects in heart development. MEFs can be 
propagated in culture but exhibit greatly reduced susceptibility to 
transformation by oncogenic Ras + Myc, E1A, or DN-p53 (Kozar et al., 2004). 
Viable Cyclin E1 Overtly normal (Geng et al., 2003) 
 
 
Cyclin E2 Viable 
Hypoplastic testes, reduced sperm count  and male infertility (Geng et al., 
2003). 
 
Cyclins E1 
and E2 
Embryos die 
by E11.5 due 
to failure of 
endoredupli-
cation of 
trophoblast 
giant cells. 
Tetraploid 
rescue 
allows most 
embryos to 
develop to 
term. 
Cardiac anomalies of varying severity in rescued embryos. Reduced 
endoreduplication in megakaryocytes. MEFs proliferate somewhat slowly 
with an increased G1 phase fraction and undergo senescence; however, 
quiescent MEFs cannot re-enter the cell cycle due to a failure in loading 
MCM proteins onto prereplication origins. MEFs resist transformation by 
oncogenicRas + Myc, E1A, or DN-p53 (Geng et al., 2003). 
Cyclin A1 
 
(only in 
male germ 
cells 
Viable 
Males are sterile due to a block of spermtogenesis before the first meiotic 
division, whereas females are normal (Wolgemuth et al., 2004). 
 
Cyclin A2 
 
(widely 
expressed) 
Embryonic 
lethality 
before E5,5 
 
Embryos develop normally until post implantation, around day 5.5. This 
observation may be explained by persistence of a maternal pool of cyclin A2 
protein until at least blastocyst stage (Murphy et al., 1997). 
 
 
Cyclin B1 Embryonic 
lethality 
(Brandeis et al., 1998) 
Viable Cyclin B2 
 
Mice are fertile, but have small litter sizes and overall reduced body size 
(Brandeis et al., 1998). 
Tab.1: Phenotypes of mice disrupted for cyclin genes 
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Disrupted 
gene 
Survival Phenotype 
 
Cdk4 
 
Viable 
 
Small body size. Most males are sterile due to hypoplastic testes and low 
sperm counts. Female sterility is due to defects in the hypothalmic–pituitary 
axis, abnormal estrus, and failure of corpus luteum. Abnormal development 
of pancreatic -islet cells leads to insulin-dependent diabetes within the first 2 
mo of life. MEFs can be propagated in culture with decreased ability to enter 
the cell cycle from quiescence; they express aberrantly high levels of 
p21C1p1 and resist transformation by oncogenic Ras + DN-p53 (Rane et al., 
1999). 
 
 
Cdk6 
Viable 
Thymic and splenic hypoplasia, and mild defects in hematopoiesis. 
T-lymphocytes exhibit delayed S-phase entry (Malumbres et al., 2004). 
 
Cdk2 Viable 
 
Meiotic failure, gonadal hypertrophy, and male and female sterility. MEFs can 
proliferate and undergo senescence and spontaneous immortalization; 
quiescent MEFs exhibit delayed entry into S phase and/or decreased ability 
to re-enter the cell cycle. MEFs can be transformed with oncogenic Ras + 
E1A, but not as efficiently as wild-type cells (Ortega et al., 2003). 
 
Progressive 
embryonic 
lethality from 
E14.5 
CDK4 and 
CDK6 
Small embryos. Partial failure of hematopoiesis results from reduced 
multipotential progenitors and multilineage deficits, including severe 
megaloblastic anemia. MEFs proliferate with increased generation time and 
reduced S-phase fraction. Some D-type cyclins associate with and activate 
Cdk2. MEFs resist transformation (Malumbres et al., 2004). 
CDK2 and 
CDK6 
Viable 
 
Phenotype identical to Cdk2 and Cdk6 single mutants (Malumbres et al., 
2004) 
 
 
Embryos die 
by E15 
CDK2 and 
CDK4 Cardiovascular defects (Santamaria et al., 2007). 
CDK4 
CDK2 
CDK6 
Embryonic 
lethality 
before E15.5 
 
The livers of live TKO embryos at E12.5–E13.5 showed a threefold reduction 
in cellularity, undergo substantial apoptosis at E13.5– E14.5, as determined 
by active caspase 3 immunoreactivity. The hearts of TKO embryos showed 
thinner ventricular walls owing to a decrease in the number of proliferating 
cardiomyocytes (Santamaria et al., 2007). 
 
p21 Viable 
 
 
Mice are more susceptible to chemically induced skin carcinoma. Female 
have decreased viability and develop a syndrome similar to human lupus 
because of increased T-lymphocyte proliferation 
 
 
p27 Viable 
 
Mice grow 20-40% large, because of alteration in the balance between 
proliferation and withdrawal from the cell cycle at the critical period of 
development. Female are infertile 
 
Tab.2: Phenotypes of mice with disrupted CDK genes 
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 1.2 Liver regeneration 
  
The liver is an important organ within the body that has a central role in 
metabolic homeostasis, as it is responsible for the metabolism, synthesis, 
storage and redistribution of nutrients, carbohydrates, fats and vitamins. The 
liver produces a large number of proteins including albumin, acute-phase 
proteins, enzymes and cofactors. Importantly, the liver is the main detoxifying 
organ of the body which removes wastes and xenobiotics by metabolic 
conversation and biliary excretion.  
The main cell types of the liver are: 
- Parenchymal cells or hepatocytes (80% of liver cells) which carry out most 
of the liver function. 
- Non-parenchimal cells (20% of liver cells) which can be  roughly 
subdivided into: 
 Endothelial cells , which line the intrahepatic vessels and provide the large 
surface area for nutrient absorption 
 
 Kupffer cells, which are located in sinusoids and play essential roles in 
phagocytosis of foreign particles and infecting organisms and the production 
of cytokines 
 
 
 Hepatic stellate cells – cells located in the portal field and around the 
pericentral area, are the principal fibrogenic cell types in the liver (Dudas et 
al., 2003). 
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The proliferative index of adult hepatocytes in the healthy liver is extremely 
low, with less than 1 per 1000 hepatocytes 
undergoing DNA synthesis at any point of time. 
Quiescent hepatocytes become proliferative and 
replicate to restore the liver functional capacity 
as well as its mass, in the case of tissue 
resection (Fig.5). This amazing regenerative 
capacity of the liver is most clearly demonstrated 
by the two-thirds partial hepatectomy (PH) 
model in rodents, which was pioneered by 
Higgins and Anderson in 1931 (Higgins and 
Anderson, 1931). In this model, 70% of the liver 
is surgically removed. The residual liver lobes 
restore the original liver mass within 
approximately one week after surgery, though 
the resected lobes never grow back. In this 
experimental system, liver regeneration does not 
require the recruitment of liver stem cells or 
progenitor cells, but involves replication of the 
mature functioning liver cells (Taub, 2004). 
 
The events of the liver regeneration can be divided into three phases 
(compare Fig.6): 
2. 
3. 
Initiation/priming 
4. 
proliferation 
However, there is no distinct border between these processes, as all 
phase are closely linked and share several mechanisms. 
Inhibition 
 
 
 
 
Fig.5: The ancient Greeks 
recognized liver regeneration 
in the myth of Prometheus. 
Having stolen the secret of fire 
from the gods of Olympus, he 
was condemned to having 
portion of his liver eaten daily 
by the eagle. His liver 
regenerated overnight, thus 
providing the eagle with 
eternal food and Prometheus 
with eternal torture. 
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1.2.1 Initiation of liver regeneration 
During initiation, hepatocytes are primed for subsequent replication. 
Initiation factors include the cytokines Tumor Necrosis Factor Alpha (TNF) and 
interleukin 6 (IL-6). 
TNF is a critical cytokine in the initiation of the regenerative process. 
Although TNF signals through both type 1 and type 2 receptors (TNFR-1 and 
TNFR-2) only signaling through TNFR-1 is required for liver regeneration after 
partial hepatectomy. This signaling pathway always follows the sequence: 
 TNF => TNFR1 => NF-κB => IL6 => STAT3  
The transcriptional factor NF-κB controls the expression of cytokine - 
encoding genes, regulates the proliferatory response and acts anti-apoptotic in 
the liver during the regenerative process. NF-κB is present as an inactive form 
in the cytoplasm, where it forms complexes with an inhibitor known as I-κB. 
Activation of NF-κB involves its dissociatiation from the inhibitor (Fausto, 2000). 
After release from I-κB, NF-κB translocates to the nucleus, where it binds to its 
recognition sequence and activates target genes. 
TNF also triggers the expression of IL-6, which is an important inducer of 
transcriptional factors and is released by hepatic stellate cells and Kupffer cells. 
During liver regeneration, IL6 activates two main cascades through the gp130-
IL-6R complex- the STAT3 and MAPK signaling pathways (Black et al., 2004). 
 
Are there other priming factors? Subsequent to priming/initiation, several 
immediate early-phase genes
S
G2G1
M
G0
Cytokines
TNF
IL-6
Growth factors
(HGF, TGFα)
Priming
Progression
Termination
 related to hepatocytes proliferation are induced 
Fig.6: Multistep model of 
liver regeneration. 
  
Liver regeneration is divided 
into three phases: priming, 
progression and termination. 
Priming is reversible 
process initiated by 
cytokines and growth 
factors. Growth factors are 
required for cells to move 
beyond a restriction pointing 
G1. In the absence of growth 
factors, cell will stop 
dividing and enter the 
quiescent 
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within 2 hours. The almost immediate activation of these genes is the first step 
in a cascade of events that leads to DNA synthesis. 
Detailed studies of the immediate early response genes revealed that 
more than 70 genes are activated during the first few hours after PH. The most 
important between them are c-fos, c-jun and c-myc (Morello et al., 1990). 
C-Jun and c-fos transcript levels increase in the liver almost immediately 
after PH and return to normal levels by 2h. This is followed by an elevation of 
the c-myc mRNA level which is highest at 2h but decreases to the basal level at 
4h. C-Jun is a critical component of the early proliferative response and induces 
the G0 to G1 transition via cyclin D (Zimmermann, 2004), while c-Myc 
expression results in the increased formation of new cyclin E/Cdk2 complexes 
and also prevents their association with of inhibitor p27 (Obaya et al., 1999). 
 
1.2.2 The proliferation phase 
Progression of primed/competent hepatocytes through G1 and subsequent 
replicative cycling is dependent on Hepatocyte Growth Factor (HGF) and 
Transforming Growth Factor (TGF-alpha) signaling after which the proliferation 
process seems to proceed autonomously under the control of cyclins and 
cyclin-dependent kinases (Taub, 2004; Zimmermann, 2004). 
HGF is synthesized by non-parenchymal cells such as Kupffer cells, 
endothelial cells and particularly Ito cells and therefore affects hepatocytes in a 
paracrine manner. HGF is a potent stimulator of DNA synthesis in hepatocytes. 
Plasma concentration of HGF increase during the first 3 hours post PH. HGF 
mRNA in the liver increases between 12 and 24 hours after operation. Elevation 
of HGF mRNA after PH is also presented in the lung, spleen and kidney. Thus 
the effect of HGF in the liver could be exerted also by the factor containing in 
the blood (autocrine).  
The production of TGF-α by hepatocytes is the critical step that leads the 
cells towards DNA synthesis, whereas gene expression changes observed 
before this point might constitute a priming state in which hepatocytes prepare 
for DNA synthesis but are not committed to enter into it. Increased levels of 
TGFα were observed within 8h after PH with a peak of expression at 24h, 
followed by a decline and subsequent smaller elevation with a peak at 72h. 
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These changes in the TGFα gene expression parallel the kinetics of DNA 
synthesis.  
 
 
 
 
 
 
 
 
 
Expression of immediate early genes and transcription-factors activation is 
followed by expression of cell-cycle related genes. They include both inducers 
and inhibitors of the cycle.  In mice, at the time between 30h and 36h post PH, 
most of the hepatocytes cross the G1/S phase boundary (Satyanarayana et al., 
2004). A peak of DNA synthesis is observed at 40h and mitosis occurs few 
hours later. This process requires a tight coordination of several pathways.  
Cyclin D1/Cdk4 or Cdk6 are activated in mid-G1, while cyclin E/Cdk2 
control G1/S phase transition. Progression of DNA synthesis is assured by 
cyclin A/Cdk2.   
Induction of cyclin E and Cdk2 occurs at time points near the G1/S 
boundary in the regenerating mouse hepatocytes. Furthermore, a subcellular 
rearrangement of cyclins and Cdks is observed in the remnant liver with cyclin E 
and Cdk2 moving from the cytosol into the nucleus. The cyclin E/Cdk2 complex 
acts as a histone H1 kinase and the peak of its activity closely correlates with 
the peak of DNA synthesis in the regenerating hepatocytes. It is suggested that 
cyclin E and Cdk2 are important in orchestrating the cell cycle in the 
regenerating liver, but the exact role of the active cyclinE/Cdk2 complex 
remains to be defined (Fausto, 2001; Starkel et al., 2005). 
 
Fig.7: Sequence of gene activation in the regenerating liver after PH. Adopted from 
Fausto, (2000)  
4h 8h 20h 48h0h
G0 G1
Immediate early 
genes(c-fos, c-
jun, jun B, c-
myc)
Delayed Genes
(bclx)
Cell Cycle Genes
(p53, p21)
DNA Replication 
and Mitosis 
(cyclin D1, 
cyclin E, B, ras)
S
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1.2.3 Termination of liver regeneration 
Subsequent to the expansion phase the growth response must finally be 
terminated. Major factors involved in the termination response comprise TGF-
beta and the activins. The mRNA levels of TGFß and activin are low or 
undetectable in normal liver but increase significantly a few hours after PH. It 
has been suggested that there is a balance between stimulators (TGFα and 
HGF) and inhibitors (TGFß and activin) of DNA synthesis during liver 
regeneration in a way that the balance favors DNA synthesis induction during 
the first hours after PH but gradually shifts toward inhibition in subsequent days. 
(Fausto et al., 1995; Michalopoulos, 1990; Steer, 1995; Taub, 2004). 
 
 1.3 Liver Fibrosis 
 
Liver fibrosis is defined as an excessive deposition of extracellular matrix. 
It is the main complication of chronic liver damage and its endpoint - the liver 
cirrhosis, is responsible for impressive morbidity and mortality.  
The most important role in the injury response and fibrogenesis in the liver 
is played by a mesenchymal cell type known as the hepatic stellate cell.  
Different types of liver injury lead to activation of cells of the immune 
system in the liver such as Kupffer cells and monocytes (Fig.8). Any activation 
of these cells leads to secretion of cytokines, among others TGF-ß. TGF-ß in 
turn leads to an activation of quiescent hepatic stellate cells. This activation 
involves changes of cell morphology but also of the protein expression pattern 
as activated stellate cells express α-smooth-muscle-actin and collagen thereby 
mainly contributing to the production of extracellular matrix. In progressing 
fibrosis, the architecture of the liver is gradually disrupted. Destruction of the 
structure of the sinusoids impairs the liver function and eventually leads to 
cirrhosis and its complications including portal hypertension and liver failure 
(Weiler-Normann et al., 2007). 
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Fig.8: Different types of liver injury lead to activation of immune cells in the liver such 
as Kupffer cells (KC), followed by secretion of cytokines, among others TGF-β.    
 
TGF-β will lead to compensatory proliferation of hepatocytes and an activation of 
resting hepatic stellate cells (HSC), which results in secretion of extracellular matrix.  
Tab. 3: Comparison of expression profiles of mesenchymal subpopulations in the liver 
(Saile and Ramadori, 2007)  
+ - strong expression, positive staining 
-  no expression, negative staining 
+/- variable expression level 
+++ - very strong expression 
?- uncertain data 
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1.4 Aim of the study 
 
It has been recently demonstrated that cyclin E1 and E2 are dispensable 
for continuously dividing cells, but are essential for both endoreplication and cell 
cycle re-entry of quiescent cells. The aim of this study was to explore the role of 
E-type cyclins during liver regeneration and fibrogenesis by using constitutive 
knockout mice for cyclin E1 and cyclin E2, respectively. 
During liver regeneration hepatocytes are activated and have to leave their 
quiescent state in order to restore liver mass. Therefore the cell cycle regulation 
during the regeneration process is an essential mechanism. From previous 
works (Geng et al., 2003) it is known that E-type cyclins are critical for cell cycle 
re-entry from quiescence and therefore play an essential role during G0/G1-S 
phase transition at least in murine embryonic fibroblasts. 
The first specific aim
The hallmark of liver fibrosis is an increase of amount of extracellular 
matrix. Many cell types are involved in that process - hepatocytes, hepatic 
stellate cells, immune cells. All of these cells are activated by fibrogenic 
extracellular signals and at least some of these cell types such as hepatic 
stellate cells and hepatocytes have to leave their quiescent state during early 
fibrogenesis. Therefore, the 
 of this study was to characterize constitutive cyclin E1 
and cyclin E2 knockout mice in the partial hepatectomy model in order to 
investigate the impact of cyclin E1 and E2 deletion on hepatocyte proliferation 
during liver regeneration. 
second aim
 
 was to investigate the relevance of E-
type cyclins in murine experimental models of liver fibrosis. 
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2. Material and methods 
 
 2.1 Materials 
 
Name of the product 
 
Company 
 
Chemicals 
Ammoniumpersulfate (APS) AppliChem  
Acetone J.T.Baker  
30% Acrylamide/Bis Solution, 37,5:1 (2,6%C) Biorad 
Agarose Invitrogen  
Acetic acid (glacial) 100% AppliChem  
Bromophenol Blue Serva  
BSA (Bovine Serum Albumin) Sigma 
Calciumchloride (CaCl2) Sigma 
Carbon tetrachloride Sigma 
Chloroform Merck 
DTT (Dithiotreitol) Sigma 
EDTA (N,N;N’,N’-Ethylendiamine-tetraacetate) Calbiochem 
EGTA (Ethylen glycol-bis (2-aminoethyl)- N,N;N’,N’- tetraacetate) Fluka  
Eosine Sigma 
Ethanol, denaturated 100 % J.T.Baker 
Ethidiumbromide (EtBr) (Stock 10 mg/ml) Sigma 
Formamide AppliChem 
Formaldehyde 37% Roth 
Glucose Merck 
Glutaraldehyde AppliChem 
Glycerol (plant) Serva 
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Glycine AppliChem 
Mayer's hematoxylin solution Merck 
Hydrochloric acid (HCl) AppliChem 
HEPES (2-[4-2-hydroxyethyl-1-piperazinyl]-ethansulfon acid) Merck 
Kalium chloride (KCl) Merck 
Magnesium chloride (MgCl2) Sigma 
Milk powder (nonfat) Merck 
β-Mercaptoethanol AppliChem 
Methanol J.T.Baker 
Natrium chloride (NaCl) AppliChem 
Nonidet P – 40 Sigma 
Paraformaldehyde Merck 
PBS (Phosphate buffered saline) 
 Biochrom 
Pepsin Sigma 
Potassium chloride (KCl) 
 Merck 
Ponceau Red 
 Sigma 
2-Propanol 
 Merck 
Proteinase K 
 AppliChem 
Salicylic acid 
 Sigma 
Sunflowe seed oil from Helianthus annuus Sigma 
Sodium citrate Roth 
Sodium hydracloride solution (NaOH) Merck 
Sodium hydrogencarbonate (NaHCO3) 
 Merck 
Tri-sodium citrate 2-hydrate 
 Roth 
SDS (Sodiumdodecylsulfate) 
 Roth 
Sodium vanadate (Na3VO4)  
 Sigma 
TEMED (N,N,N’,N’-Tetramethylethylendiamine)  
 Sigma 
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Triton X-100 
 
Sigma 
TWEEN-20 Sigma 
Radiochemicals 
[32P]-γ-ATP (10mCi/ml) Hartmann Analytic 
Analytical chemicals, reagents and kits 
ATP (Adenosintriphospate; 10mM) Invitrogen 
Biorad reagent® Biorad 
Cell Proliferation (BrdU) Kit®BrdU GE  Healthcare 
Complete Mini® (Proteinase Inhibitor Cocktail)  Roche 
Covering solution for cryo sections (Tissue-Tek®)  Sakura 
3,3diaminobenzidine tablet sets (SIGMA FAST©) Sigma 
DNA marker 1kbplus Ladder®  Invitrogen 
Pierce ECL Western blotting Substrate Pierce 
Mouse Chromosome Y paint Cy3 labelled Cambio  
Histone H1 recombinant (5μg/ml)  Upstate 
Liberase Blendzyme®  Roche 
Mounting Medium®  Vector 
Oligo-dT Primers  Qiagen 
Omniscript RT Kit Qiagen 
Protein HighRange Rainbow Molecular Weight marker®  Amersham 
peqGOLD-RNAPure®  Peqlab 
Protein A agarose beads Roche 
Random Primers (3μg/μl) Invitrogen 
ReadyMix redtaq PCR reaction mix Sigma 
SYBR® GreenER qPCR SuperMix  Invitrogen  
RNAse (1mg/mL) Sigma 
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Antibodies 
anti-Cdk2 (M2;  sc-163); Santa Cruz 
anti-cyclin A (C-19; sc-596);  Santa Cruz 
anti-cyclin D1 (72-13G; sc-450);  Santa Cruz 
anti-cyclin B (M20: sc 595) Santa Cruz 
anti-cyclin E (M20; sc 481) Santa Cruz 
anti-GAPDH  Biogenesis  
anti Histone H3 antibody Cell Signalling  
anti-PCNA antibody Dianova 
HRP-linked anti-mouse immunoglobulin G (sc-2005) Santa Cruz 
HRP-linked anti-rabbit immunoglobulin G (#7074) Cell Signaling 
secondary anti-rabbit antibody Alexa Fluor 488 Molecular probes 
secondary anti-mouse antibody Alexa Fluor 488 Molecular probes 
Instruments and equipment 
Blotting Trans-BlotTM  Cell BioRad 
Cell culture centrifuge Megafuge 1.0R Heraeus 
Cell culture flow  Gelaire 
Cell culture Incubator  Heraeus 
Centrifuge 5415D  Eppendorf 
Cooling centrifuge 5417R  Eppendorf 
Cytospin centrifuge  Hettich Universal 
Cryostat HM 550  Microm 
ELISA Reader μQuant + KC4 Software BIO-TEK 
FACS Canto flow cytometer  Becton Dickinson 
FlowJo Software 7.1.2 Tree Star Inc., OR 
Overhead shaker REAX 2  Heidolph 
Perfusion pump  Ismatec 
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pH Meter PB-11  Sartorius 
Powersupply PowerPac HC BioRad 
7300 Real Time PCR System Applied Applied Biosystems 
Sequence Detection Software Version 1.3.1. Biosystems 
Roller Mixer SRT 9  Stuart 
Rotating incubator  Bachofer 
SDS PAGE electrophoresis system PerfectBlue Twin L  Peqlab 
Thermocycler T3000 and Tpersonal  Biometra 
Thermomixer 5436  Eppendorf 
UV Stratalinker  Stratagene 
Water bath Haake W13  Fisons 
Weighing maschines  Sartorius 
General materials  
Hybond N membranes  Amersham 
Tubes for FACS BD Biosciences 
Filter pipet tips (10, 100, 1000μl) VWR 
96 well Microplates for RT-PCR Star 
96 wells Micrplates for protein measuring Greiner 
96 wells Micrplates for RNA measuring Greiner 
Nitrocellulose membrane Protran ® Whatman 
Super Frost slides  Roth 
Multiply-PCR Strips Sarstedt 
Eppendorf Tubes 2,0ml Eppendorf 
X ray films  Amersham 
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Material for animal experiments 
Catheter with injection port (Biovalve® 20G; 1,0x32mm)  Vygon 
Disposable Scalpels sterile No. 10, 11, 21  Feather 
Ethibond® Excel plated, laminatet, not absorbable; 6/0 metric 0,7  Ethicon 
General chow for rodents  Altromin 
Hematocrit capillary  Brand 
Heparine (Liquemin®) Roche 
Injection needles (Sterican®; Gr.17 24Gx25mm; 0,4x12mm)  Braun 
Isoflurane (Forene®)  Abbott 
Ketamine (Ketamin®)  Albrecht 
Micro tube (1,1 ml Z-Gel) Sarstedt 
Surgical instruments  Aesculap 
Syringe Omnican® Braun 
Vicryl®, absorbable 4-0  Ethicon 
Xylazin (Rompun®)  Bayer 
 
 
 
 2.2 Methods 
 
2.2.1 Housing and breeding of mice 
All animals used for experiments were maintained in the animal facility of 
the University Hospital Aachen in a temperature controlled room with 12-hour 
light/dark cycle according to the German legal requirements. For our study we 
used previously described constitutive knock-out mice for cyclin E1 (E1-/-) and 
cyclin E2 (E2-/-) on a 129/Ola background (Geng et al., 2003) of male gender. 
As controls, we used wildtype (WT) littermates derived from heterozygous 
breeding couples.  
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2.2.2 Partial hepatectomy (PH) and tissue sampling 
For liver regeneration studies, midioventral laparotomy with two third 
partial hepatectomy was performed according to the method of Higgins and 
Anderson (Higgins and Anderson, 1931). Five to eight week-old males (E1-/-, 
E2-/- and WT) were anesthetized intraperitonealy with a combination of 10% 
Ketamin and 2% Xylazinhydrochlorid in 0.9% NaCl. A midline lapartomy was 
done. The major liver lobes were identified - anatomically, the median lobe, with 
its two central portions together with the left lateral lobe, forms somewhat of a 
unit which lends itself to surgical removal. First these liver lobes were ligated 
with the silk tie and then ligated tissues were resected. The abdomen was 
closed with two layers. After operation animals immediately got access to water 
and food.  Five to ten mice from each group were sacrificed before or at 
different times after PH. The remnant liver was extracted for the weight 
measurement and further molecular and histological analysis. A portion of liver 
was immediately snap frozen in liquid nitrogen for protein and RNA isolation, 
whereas another portion was frozen in Tissue-Tek or stored in 4% 
paraformaldehyde (PFA) before paraffin embedding.  
As a model of fatal hepatic failure we performed 90% hepatectomy with a 
subset of animals as described recently (Makino et al., 2005). The surgery 
procedure was similar to the 2/3 hepatectomy. However, in these experiments 
all liver lobes except the caudate were resected. 
 
2.2.3. Isolation and analysis of DNA 
2.2.3.1. Isolation of genomic DNA from tail biopsies 
To genotype mice by PCR, DNA was isolated from murine tail tips of 
around 0.3 cm in length. The tissue was lysed for at least 3 hour at 56°C in 500 
μl of lysis buffer containing 20 μl of proteinase K (15,6 mg/ml). The samples 
were centrifuged for 10 minutes at 14000 rpm. 500 μl of 2-propanol were added 
to the achieved supernatant for precipitation. After mixing thoroughly 
centrifugation was performed for another 10 minutes. Supernatant was 
discarded and the nucleic acid containing pellet was washed twice in 70% 
ethanol for removal of salts by mixing and subsequent centrifugation at 14000 
rpm for 2 minutes. The pellet was dried at 37°C and resuspended in 200 μl 1M 
RNAse/TE. Storage was carried out at 4°C. 
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Lysis buffer:  
25 ml 1M Tris-HCl, pH 8,0   = 50 mM Tris 
100ml 0,5M EDTA, pH 8,0 = 100 mM 
50 ml 1M NaCl =  100 mM 
25 ml 20% SDS = 1 % 
300ml H2O 
 
2.2.3.2. Genotyping 
The genotypes of genetically modified mice were determined by PCR 
analysis from mouse tail biopsies according to standard procedures. 
A PCR specifically detecting the gene disruption of cyclin E1 was 
performed using the following thermocycling program: 
 
Procedure Temperature Duration Cycle 
Denaturation 95°C 2min 1 
Denaturation 98°C 15s 36 
Annealing Tm 52°C 30s 36 
Elongation 72°C 30s 36 
Extension 72°C 2m 1 
Conservation 4°C ∞  
 
The primers were used are: 
3N3 (5- GAT CTC TCG TGG GAT CAT TG -3),  
11-2 (5- CGC ATA CTG AGA CAC AGA CT -3), 
E11-A ( 5- CGC CAT GGT TAT CCG GGA GAT GG-3). 
 The knock-out (KO) band is about 300 bp and the wild type (Wt) band is 
about 180 bp. 
 
The knockout of cyclin E2 was identified with the same PCR program 
using the following primers:  
3N3 (5- GATCTC TCG TGG GAT CAT TG -3), 
E2G (5 GGT TCT CCC ATT TAG AGC ACA G-3), 
E2L (5 GCT ATA GCA GTT GTT TCT GTT TG-3). 
The KO band is about 300 bp and WT band is about 400 bp.  
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PCR Reaction Mix: 
2 µl DNA template (100 ng) 
1 µl Sense Primer 1 (10 pmol/ µl) 
1 µl Sense Primer 2 (10 pmol/ µl) 
1 µl Antisense Primer  (10 pmol/ µl) 
12,5 µl Ready MixTM redtag PCR reaction mix with mgCl2  
7,5 µl H2O 
25 µl final volume 
 
 
2.2.4  Isolation and analysis of RNA 
2.2.4.1 Isolation of RNA from liver tissue 
From deep frozen liver tissue around 50-100 mg was cut off on dry ice and 
1 ml of peqGOLD-RNAPure® was added. After homogenization using an Ultra-
Torrax the lysate was incubated for 5 minutes at room temperature. After 
adding 200μl of chloroform under an extractor hood the sample was vortexed 
thoroughly for 15 seconds and again incubated at room temperature for 10 
minutes. Due to centrifugation at 12000 x g for 5 minutes the lysate formed up 
three phases. The liquid upper phase contains the disassociated RNA, whereas 
the interphase and the lower phase contain impurities of DNA and protein. 
Avoiding any contact with the interphase, the upper phase was transferred 
carefully to a fresh reaction tube. After addition of 500μl 2-propanol samples 
were incubated for 10 minutes at room temperature. Precipitated RNA was then 
isolated by centrifugation for 10 minutes at 12000 x g and 4°C. After discarding 
the supernatant the pellet was washed twice with 1 ml 70% ethanol. For 
washing, centrifugation was performed at 12000 x g at 4°C for 10 minutes. 
Subsequently the pellet was dried for 30 min on ice and dissolved in 40-80 μl 
RNAse-free dH2O. Storage of isolated RNA was performed at -80°C. 
 
2.2.4.2 Determination of RNA concentration 
Purified RNA was diluted 1:50 in RNAse-free dH2O to measure optical 
density at 260nm (OD260). The RNA concentration was calculated according to 
the formula: 1OD260 = 40 μg RNA/ml. The purity of RNA was analyzed with 
additional determination of the extinction at 280nm. A ratio of E260/E280 
between 1.9 and 2.1 accounts for pure RNA. 
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2.2.4.3 Reverse Transcription (RT-PCR) 
Reverse transcription is a process in which single-stranded RNA is reverse 
transcribed into complementary DNA (cDNA) using the enzyme reverse 
transcriptase. In combination with real time PCR this method is applied for 
profiling mRNA gene expression.  
Reverse transcription (RT) reactions were performed with an Omniscript 
RT Kit and OligodT primers (Qiagen, Hilden, Germany) according to the 
manufacturers instructions using the following parameters: 
 
Reaction Mix: 
Template RNA 2 μg 
10x BufferRT (Omniscript RT Kit; Omniscript RT Kit ) 2,0 μl 
dNTP Mix (5 mM each dNTP;Omniscript RT Kit ) 2,0 μl 
Oligo-dT primer (10 μM;Omniscript RT Kit ) 2,0 μl 
Omniscript Reverse Transcriptase 1,0 μl 
RNase –free water  variable 
Total volume 20,0 μl 
 
Thermocycling program: 
60min – 370C 
5 min - 93 0C 
 
2.2.4.4 Quantitative real-time PCR 
Relative gene-expression of cell cycle relevant genes (cyclin E1, E2, A2, 
D1, B1, p21 and p27) was measured via real-time PCR using a 7300 Real Time 
PCR System with SDS software 1.3.1 and a SYBR Green PCR Kit (Invitrogen). 
 
Reaction Mix: 
5μl cDNA template  
2 μl sense primer (100μM) 
2 μl antisense primer (100μM) 
12,5 μl SYBR® GreenER qPCR SuperMix 
3,5 μl H2O 
25 μl final volume 
 
Measuring was normalized using GAPDH expression as internal standard. 
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PCR was performed for 40 cycles with annealing at 58°C and elongation at 
60°C using the following primers:  
 
 
Quantitative real-time PCR for cyclin E1 and E2 was performed 
accordingly using standards containing defined numbers of cyclin E1, E2 and 
GAPDH cDNA molecules in a range of 108 -101. Expression was calculated as 
number of target molecules/106 GAPDH molecules.  
 
2.2.5. Isolation and analysis of proteins 
2.2.5.1 Protein isolation and quantification 
Liver tissues were homogenized in 500μl of lysis buffer containing 50mM 
Tris-HCl; 150mM NaCl; 0.5% NP40; 0.1M NaVO3; 1M DTT; 100mM PMSF and 
protease inhibitors (Complete MINI©, Roche). 
Protein concentrations were determined using a Bio-Rad Protein Assay 
according to manufacturer’s instructions. Different concentrations of BSA (2, 4, 
6, 8 and 10 mg/ml) were used as standards. 2 μl of protein sample was added 
to 998 μl of the 1:5 diluted dye reagent. The absorbance was measured at 595 
nm, which allowed calculation of protein concentration deduced from a BSA 
standard curve. 
 
Gene sense primer (5’-3’) antisense primer (5’-3’) 
cyclin D1 AAGCATGCACAGACCTTTGTGG TTCAGGCCTTGCATCGCAGC 
cyclin B1 CTGCACTTCCTCCGTAGAGC AAAATGCACCATGTCGTAGTCC 
cyclin A2 CAACAGTAAATCAGTTCCTTACC CATCTATCAAACTCAGTTCTCC 
cyclin E1 ACAGCAGGTCTTCGTGCAGATC CTGAAGCAGCCACAT CCAG 
cyclin E2 CCATGGAAGATAGACACAATATCC CATAATGCCTCCATTACACACTGG 
p21: TTGCACTCTGGTGTCTGAGC TCTGCGCTTGGAGTGATAGA 
p27 GACAATCAGGCTGGGTTAGC TCTGTTCTGTTGGCCCTTTT 
collagen 1 TTCACCTACAGCACGCTTGTG GATGACTGTCTTGCCCCAAGTT 
αsma AAAAAAAACCACGAGTAACAAATCAA TCAGCGCCTCCAGTTCCT 
GAPDH TGTTGAAGTCACAGGAGACAACCT AACCTGCCAAGTATGATGACATCA 
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2.2.5.2 Western blot 
Samples containing 30μg of protein and loading dye were heated for 5 
minutes at 95°C and were then applicated to sodium dodecyl sulfide 
polyacrylamide gel electrophoresis. Separating was performed between 50 and 
120 V in Rotiphorese 1x SDS page running buffer. 
 
Composition of separating gel 
Compounds 8% 10% 12,5% 
H2O 4,6 ml 4,0 ml 3,28 ml 
Tris M 1,5 pH 8,8 2,5 ml 2,5 ml 2,5 ml 
Acrylamid 2,7 ml 3,3 ml 4,06 ml 
10% SDS 100μl 100μl 100μl 
10% APS 100μl 100μl 100μl 
TEMED 6,0 μl 7,5 μl 7,5 μl 
 
Composition of collection gel 
Compounds 3% 
H2O 3,1 ml 
Tris M 1,5 pH 8,8 1,25 ml 
Acrylamid 0,5 ml 
10% SDS 50μl 
10% APS 25μl 
TEMED 7,5 μl 
  
After electrophoresis, proteins were transferred to a Nitrocellulose 
Membrane (PROTRAN ©) using a wet western blotting system (BioRad) for 2 
hours at 300 mA. Membranes were blocked for 30 min in 5% Dry-Milk/TBS-
Tween and incubated with primary antibodies in 5% Dry-Milk/TBS-Tween 
overnight at +4°C. Antibodies for cyclin E, B1, D1 and A were diluted 1:500; the 
GAPDH antibody was used at a 1:10000 dilution. Washing of membranes was 
performed three times for 10 min in TBS-Tween followed by incubation with a 
secondary antibody (anti-rabbit HRP-linked IgG) diluted 1:5000 in 5% Dry-
Milk;TBS-Tween; 2% BSA or anti-mouse Ig-HRP for 1 hour, followed by 
washing in TBS-Tween. The antigen-antibody complexes were visualized by 
using ECL Western blotting Substrate (Pierce). 
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2.2.5.3  Immunoprecipitations and in vitro Kinase assays  
A total of 500 μg of liver protein extracts were subjected to 
immunoprecipitation using 1μg of cdk2 antibody at +4°C overnight and then 
conjugated to Protein-A agarose beads. Immunoprecipitated complexes were 
collected by centrifugation, washed 2 times with NP40 buffer and once with 
Histone-washing buffer. After final centrifugation, pellet was incubated for 30 
min at 37°C with 2µg recombinant Histone H1, 100mM ATP and 7 μl of 32P-
γATP (10µCi/µl). Reaction was stopped by adding SDS loading buffer (10% 
glycerol, 1% SDS, 25mM Tris-HCL). Samples were separated on 10% SDS-
PAGE-gels and analyzed by autoradiography. 
For Cyclin A depletion experiments, a total of 500 μg of liver protein 
extracts were first subjected to immunoprecipitation using 1μg of cyclin A 
antibody for 2h at +4°C and then conjugated to Protein-A agarose beads for 2h. 
After 2min of gentle centrifugation, the supernatant containing cyclin A-depleted 
liver proteins was collected and subjected to immunoprecipitation with cdk2 
antibody (2h, at +4°C). Kinase assays with immunoprecipitated complexes were 
carried out as described before. 
 
Histone washing buffer:                                    
2,5 ml Tris-HCl pH7,5 = 25mM 
7,7 ml 1M NaCl = 70 mM 
2 M MgCl2 = 10mM 
200 1µl 1M DTT = 1mM 
 
SDS loading buffer:  
15ml 100% Glycerol = 50% Glycerol 
3g SDS = 5% SDS 
7,5 ml 0,5 M Tris-HCL, pH 6,8 = 125mM 
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2.2.6 Work with primary cells  
2.2.6.1 Isolation of hepatocytes 
Primary mouse hepatocytes were isolated by a two- step collagenase 
perfusion technique. Mice were anesthetized intraperitonealy (i.p.) with a 
combination of 10% Ketamin – 2% Xylazinhydrochlorid  in 0.9% NaCl.  40 IE 
Heparin in 300µl 0.9% NaCl were injected i.p. prior to liver perfusion to avoid 
blood coagulation. Midline laparotomy was performed, the vena cava inferior 
was cannulated and the portal vein was cut immediately.  Mouse liver was 
retrograde perfused with the warmed up solution at 6 ml/min with 40 ml 
Hepatocyte buffer (HB)  in the presence of  1 mM EDTA followed by second 
perfusion of HB containing 2mM CaCl2, and Liberase 3™ (14 mg/l) (0.7mg in 
50ml of HB), (Roche). After perfusion, the liver was carefully extracted, minced 
in 10 ml of HepatoZyme-SFM medium (Invitrogen), filtered through 70µm cell 
strainer (BD Bioscience) and immediately stored on ice. 
Hepatocytes buffer (pH 7.4) 
0,15 M NaCl 
6 mM KCl 
5mM glucose 
0,02 M Hepes 
2,5 M NaHCO3  
 
2.2.6.2 Analysis of DNA content by Fluorescence Activated Cell Sorting 
(FACS)  
Freshly isolated primary hepatocytes were centrifuged at 50g for 5 minutes 
at 4°C. The supernatant was discarded and the cell pellet was washed twice 
with PBS at 50g. Hepatocytes were resuspended in Nicoletti buffer at a cell 
density of 106 cells/ml. Probes were measured using a FACS Canto flow 
cytometer in the PerCP-Cy5-5 channel. For each measurement, a minimum of 
105 cells were analyzed. Analysis was performed with FlowJo Software 7.1.2. 
Ploidy fractions were counted in percentages excluding the apoptotic cell 
population. 
Nicoletti buffer (pH 7.4) 
 0.1% Sodium citrate 
 0.1% Triton X-100;  
50 μg/ml Propidium iodide 
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2.2.6.3 Fluorescent In Situ Hybridization (FISH) 
Primary mouse hepatocytes were isolated 96 hours post PH and 
immediately transferred to glass slides using a cytospin centrifuge. Slides were 
shortly dried at room temperature and then fixed in methanol/acetic acid (3:1) 
for 10 min, and treated with RNAse (1mg/mL) for 1 h at 37°C in a humidified 
chamber. The samples were dehydrated in an ethanol series (70%, 80%, 
90%,100%) and air dried followed by incubation in 0,01M HCl containing 5% 
pepsin. Slides were fixed in 4% PFA, dehydrated in an ethanol series (70%, 
80%, 90%, 100%), air dried and subjected to aging at 65°C for 60 min. For 
denaturation of chromosomal DNA, slides were incubated in 70% formamide/2 
X SSC at 70°C for 5 min, dehydrated by serial ethanol washing for 2 min each 
in 70%, 80%, 90%, 100% ethanol and air dried. A probe corresponding to the 
murine Y chromosome was prepared according to the manufacturer’s 
supplementary protocol. 15 μl of Cy3 labelled probe was applied to each slides 
under cover slips. The hybridization was performed overnight at 37°C in a 
humidified chamber. Post hybridization washings were carried out at 58°C in 
2xSSC, followed by Stringency Wash Solution (deionised Formamide/1*SSC = 
1:1) and 1xSSC; each washing step was performed twice for 5 min. After that 
slides were immersed in Detergent Wash solution (0,05% Tween20 in 4*SSC) 
for 4 min and mounted with Vectashield containing DAPI. Cells were examined 
with a Carl Zeiss fluorescence microscope using a Ds Red 43 filter. Three 
hundred to 1000 nuclei of each mouse strain were analyzed and the percentage 
of nuclei containing 2, 4 or more than 4 signals was determined. 
 
10xSSC pH7,2 
Natrium Chloride  87,65g 
Natrium Citrat 44,1g 
H2O 1000 ml 
 
2.2.7 Quantification of liver proliferation and immunhistochemistry 
2.2.7.1 PCNA Staining  
5 μm cryosections were fixed in 4% Formaldehyde/PBS, followed by 
washing with PBS for 5 min. Slides were incubated in methanol containing 3% 
H2O2 for 10 min and then washed in PBS 5 min. Sodium Citrat (10mM; pH 6.0) 
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was preheated in a microwave oven for 5 min at 800 W, then slides were 
immersing in hot Sodium Citrat for 15 min in the microwave oven at 240 W. The 
slides were cooled down to room temperature and washed three times in TBS-
Tween for 3 min. After that, incubation with an anti-PCNA antibody (Dianova) at 
a dilution of 1:200 was performed at +4°C overnight. The slides were washed 
three times in PBS for 3 min and incubate for 30 min at room temperature with a 
secondary anti-mouse antibody (goat anti-mouse IgG2aHRP Sc-2061) at a 
dilution of 1:100. Washing was performed 3 x 3 min in PBS, followed by staining 
with DAB solution and counterstaining with haematoxylin. The reaction was 
stopped by washing into distilled water for 5 min. PCNA positive cells were 
calculated as a percentage to all nuclei per field at 20x magnification. 
 
2.2.7.2 BrdU Labeling 
For in vivo labeling experiments, 5-2-deoxyuridine (BrdU) was injected i.p. 
(30 µg/g body weight) 2 hours before animals were sacrificed. Liver tissues 
were immediately frozen in Tissue-Tek.  
Protocol1 (bright field microscopy): 5 μm cryosections were fixed in ice-
cold acetone-methanol (50%-50%) for 10 min and then washed 5 min in TBS-
Tween (pH 7.6) two times. The slides were dehydrated in 70% ethanol for 30 
min and dried for 30 min at room temperature. The block of endogenous 
peroxidase activity was done by incubating in methanol/3% H2O2 in for 10 min, 
followed by washing 2x5 min in TBS-Tween. Denaturation was made by 
immersing slides for 30 min in 70°C Formamide/NaOH, washing by 5 min TBS-
Tween at 70°C, and then immersing in 0.15 M 6ml Natriumcitrat in 100 ml 
Formamid during 15 min. The reaction was stopped by washing slides in ice-
cold TBS-Tween (2 times 7 min). A second fixation was performed in PBS/3% 
formaldehyde for 30 min. After that slides were washed in TBS-Tween 2 times 
for 5 min and then immersed in 25% Glutaraldehyde. Washing was made in 
TBS- Tween 2x5 min. Slides were incubated in a light-protected wet chamber 
overnight at +4°C with a primary anti BrdU antibody (Amersham Bioscience). 
The next day, washing was performed four times for 4 min in TBS-Tween, 
followed by incubation with a secondary anti-mouse antibody 1:100 (goat anti-
mouse IgG2aHRP) for 30 min at room temperature. Samples were washed 4 x 4 
min with TBS-Tween and slides were shortly incubated with DAB solution 
(SIGMA FAST), followed by immersing in Haematoxylin solution (10 min) and 
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washing in distilled water (5 min). Samples were analyzed in a light microscope 
at 20 x magnification. The BrdU index was calculated as percentage of BrdU 
positive cell to all nuclei per field. 
 
Protocol 2 (fluorescence microscopy): Cryosections (5 µm) were air-dried 
and fixed with ice-cold acetone for 15 min. After rehydration with 1xPBS for 5 
min, samples were treated with 2 N HCl for 30 min and neutralized with 0.1 M 
sodium borate (pH 8.0) for 10 min. Samples were washed 3 times with PBS. 
Slides were incubated in dark wet chamber overnight at +4°C with a primary 
anti-BrdU antibody (1:40). Washing was performed 3 times for 10 min in TBS-
Tween, followed by 1 h incubation with secondary anti-mouse antibody (Alexa 
Fluor 488). Slides were washed twice in TBS-Tween and mounted with 
Vectashield containing DAPI. Sections were analyzed with a fluorescence 
microscope.  
 
2.2.7.3 Measurement of histone H3 phosphorylation. 
Frozen 5 μm liver sections were fixed in ice cold Acetone-Methanol 
(50%/50%) for 10 min, dried and then rinsed in PBS-Tween for 10 min. Slides 
were blocked with goat serum for 45 min. Incubation with anti-Histone H3 
antibody was done at +4°C at a dilution of 1:200 overnight, followed by 3 x 10 
min washing in PBS-Tween. Slides were incubated with fluorescence-labeled 
secondary anti-rabbit-antibody (AlexaFluor 488) for 1 hour in a dark humidified 
chamber at room temperature. Slides were washed twice in PBS-Tween and 
mounted with Vectashield containing DAPI. 
 
2.2.7.4 Histological analysis and morphometry 
Hepatic tissues were fixed in 4% PFA immediately after extraction, 
embedded in paraffin, sectioned and first fixed in acetone for 10 minutes. For 
staining nuclei of liver cells, sections were immersed in Mayer's hematoxylin 
solution for 8 minutes and then thoroughly rinsed in running tap water for 10 
minutes. Counterstaining was performed with 1% eosin solution for 1 minute. 
Afterwards, dehydration was carried out in first 70% and then in absolute 
alcohol for 2 minutes each. Slides were subsequently immersed in Rotihistol for 
2 minutes and cover with cover glass. 
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The histological analysis was kindly performed by Prof. Dr. Nikolaus 
Gassler (Institute of Pathology, University Hospital Aachen). For morphometric 
analysis, from two DAPI-stained independent tissue sections per mouse, 10 
magnification areas were randomly selected and subjected to computer-aided 
morphometry using an eclipse 80i fluorescence microscope in combination with 
image quantifying software NIS-Elements BR2.30 (Nikon).   
 
2.2.8 Generation and in vivo use of recombinant cyclin E2 adenovirus 
(adv-CcnE2) 
The plasmids pΔE1sp1A (Bett et al., 1994) and pJM17 (McGrory et al., 
1988) used for construction of the adenoviral vector were obtained from 
Microbix Biosystems Inc. (Toronto, Ontario, Canada). A 2.2 kB DNA fragment 
containing the 1.4 kB open reading frame of the murine cyclin E2 gene under 
control of the cmv-promoter was cloned into the EcoRI and BglII sites of 
pΔE1sp1A, respectively, resulting in pΔE1sp1A-CMV-CcnE2. The integrity of 
cloning boundaries were verified by restriction analysis and sequencing with 
flanking primers 5' - GCGTAACCGAGTAAGAATTTG - 3' and 5' – 
GGCGACCATCAATGCTGGAG - 3', respectively. Integration of vector 
sequences from pΔE1sp1A-CMV-CcnE2 into the adenoviral backbone vector 
pJM17 was performed by in vitro homologous recombination in the human 
embryo kidney cell line 293 in cooperation with Prof. Dr. Weiskirchen (Institute 
of Clinical Chemistry and Pathobiochemistry, University Hospital Aachen) as 
described before (Weiskirchen et al., 2000). Successful generation of 
recombinant viral particles were visualized by viral foci formation. After total 
infection viral particles were released from cells by three rounds of a freeze-
thaw cycle. Viral particles were separated from cell debris by centrifugation at 
3000 rpm for 10 minutes. To generate higher titer viral stocks, 293 cells were 
re-infected at a multiplicity of infection (MOI) of 1 and grown for 3-4 days, at 
which time amplified viruses were harvested, concentrated through standard 
CsCl gradient centrifugation and subsequently purified using the BD Adeno-XTM 
Purification Filter system (BD Biosciences, Clontech, Palo Alto, CA) according 
to the manufacturer’s instructions. 
For in vivo application of adv-CcnE2, a virus suspension containing 1.2 X 
1010 plaque forming units (pfu) were injected i.v. via tail vein into mice 24 hours 
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before hepatectomy. As control, an adenovirus expressing cmv-luciferase (adv-
Luc) was used.  
 
2.2.9 Induction of Liver Fibrosis with CCl4  
Hepatic fibrosis in mice was induced by introperitoneal injections with 0.6 
ml/kg body weight of CCl4 dissolved in sunflower oil, 2 times per week for up to 
4 weeks. 
 
2.2.10 Sirius red staining 
Liver tissues were fixed in formalin (3.5%) and embedded in paraffin. Liver 
sections of 5 µm thickness were incubated in a solution containing 0.1% Sirius 
red and 0.1% Pikrinacid (pH 2.0) for 1 hour. Then sections were treated with 
0.01M HCl for 2 minutes, washed in H2O, fixed in an ascending sequence of 
ethanol and covered.  
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3. Results 
 
 3.1 Cyclin E1 – and cyclin E2 deficient mice have different 
kinetics of S-phase initiation after partial hepatectomy 
 
In the adult liver, hepatocytes are normally quiescent, highly differentiated 
cells. However, after a regenerative stimulus such as 70% partial hepatectomy 
(PH) they rapidly switch to the proliferative state and re-enter the cell cycle. To 
study the role of cyclin E1 and E2 during liver regeneration in mice, PH was 
performed with E1-/-, E2-/- and WT mice and the livers were analyzed for cell 
cycle progression of hepatocytes in a time frame of 24-168 hours after surgery. 
For each time point a minimum of five animals per group was investigated. Of 
notice, all animals survived the surgical intervention. 
The Proliferating Cell Nuclear Antigen (PCNA) is a processivity factor for 
replicative DNA polymerases (Maga and Hubscher, 2003) serving as an 
essential factor for initiation of DNA synthesis. Therefore, first G1-S phase cell 
cycle progression was studied by analyzing nuclear PCNA expression in 
histological cryosections of liver tissues at different time points after PH.  
In WT animals, PCNA expression in the liver started 36 h after surgery and 
peaked at 40 h after PH followed by a continuous decrease of PCNA positive 
hepatocytes to almost baseline level until 168 h (Fig. 8).  
In comparison, E1-/- mice showed only a slight delay of 4 h in the onset of 
PCNA expression (Fig. 8 A, B) and had an expression maximum 48 h after 
surgery (Fig. 8 B). However, between 48-96 h post PH the total number of 
PCNA positive hepatocytes was significantly higher compared to the WT 
control.   
In striking contrast to these findings the PCNA expression pattern in E2-/- 
mice was completely different showing three times more PCNA-positive nuclei 
already 36 h after surgery (38% compared to 13% in WT animals) with no 
obvious expression peak but a continuous high expression level up to 72h after 
surgery (Fig. 8 A, C).   
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Fig.8: Quantification of G1-S phase transition  
Immunhistochemical staining for PCNA on liver cryosections at 36 h and 72 h after PH. 
White arrows indicate examples of PCNA-positive nuclei (A). Quantification of staining by 
calculating the percentage of hepatocytes showing PCNA in liver tissues of WT 
compared to E2-/- mice (B) or WT compared to E1-/- mice  (C) at time 0h to 168 h after PH. 
Each value represents the mean of 5-10 mice. (*) p < 0.05; (#) p < 0.05. 
 
This initial analysis indicated that E1-/- - and E2-/- mice have different 
kinetics in G1-S phase transition. To link this result to the function of either E-
type cyclin, the activity of the cdk2 kinase complex was analysed by measuring 
in vitro histone H1 phosphorylation. Cyclin E/Cdk2 kinase complexes have been 
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described as the main regulators for G1-S phase transition (Pines, 1995) and 
histone H1 serves as a prominent substrate of this kinase showing maximal 
phosphorylation at the peak of DNA synthesis in the regenerating hepatocytes 
(Jaumot et al., 1999). 
 In WT mice histone H1 phosphorylation was evident exclusively between 
40 h and 48 h after PH (Fig 9, upper panel) which is consistent with previous 
studies (Dierssen et al., 2008). In contrast, E1-/- mice showed stronger and 
prolonged cdk2 activation until 72 h post PH compared to control animals  
(Fig. 9, medium panel). In coincidence with the PCNA expression pattern, E2-/- 
mice showed a strong induction of cdk2 activity already after 36 h up to 72 h 
(Fig. 9, lower panel). In addition, cdk2 kinase activity was also evident in E2-/- 
mice 96 h after PH although to a lesser extend. 
 
 
 
 
 
 
 
 
 
 
Fig.9: Determination of cdk2 kinase activity 
 
A total 500µg of protein extract from mouse livers of WT, E1-/- and E2-/- mice harvested 
between 0 h and 168 h post PH were subjected to immunoprecipitation using an anti-
cdk2 antibody and histone H1 kinase assay were performed with the immune complexes. 
The signals indicating phosphorylated histone H1 are highlighted by arrows. 
 
However, cdk2 kinase activity can be mediated via cyclin E/cdk2 or cyclin 
A/cdk2. In further experiments these two complexes were dissected by first 
depleting cyclin A/cdk2 activities using an anti-cyclin A antibody and 
subsequent analysis of the remaining, cyclin A-free protein extracts by histone 
H1 kinase assays (Fig. 10). In E1-/- mice, depletion of cyclin A resulted in a 
substantial reduction of cdk2 kinase activity both 40 h and 72 h after PH, 
indicating that cyclin E1 deficiency is predominantly substituted by cyclin A. In 
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contrast, deprivation of cyclin A did not affect total cdk2 activity in E2-/- animals 
72 h post PH and only to a minor extend at 40 h after surgery. This suggests 
that the prolonged S-phase and kinase activity seen in E2-/- mice is mediated by 
cyclin E1/cdk2.  
 
Fig.10: Dissection of cyclin E/cdk2- and cyclin A/cdk2 kinase activities.  
Protein extracts from WT, E1-/- and E2-/- mice after PH were depleted for cyclin A/cdk2 
complexes by immunoprecipitation with an anti-cyclin A antibody where indicated and 
subjected to histone H1 kinase assays in comparison to untreated extracts representing 
total cdk2 activity. 
 
RB phosphorylation through cyclin E/cdk2 kinase is a key event for G1/S-
phase transition eventually leading to release and activation of E2F transcription 
factors. E2F may further activate E- and A-cyclins as well as its own 
transcription thereby initiating a positive feedback loop. Therefore, RB 
phosphorylation and E2F gene expression was analyzed in WT, E1-/- and E2-/- 
mice.  
In WT mice, slight RB phosphorylation was evident 36 h after PH but 
hyper-phosphorylation of RB was restricted to 48 h after surgery (Fig. 11 A). 
Interestingly, E1-/- mice displayed a similar RB phosphorylation pattern but 
showed stronger RB phosphorylation at 48 h post PH (Fig. 1E) which correlated 
with increased PCNA expression However, these animals also show a delayed 
onset of E2F1 expression (Fig. 11B) indicating that not a lack of cdk2 kinase 
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activity, but absence of E2F1 may contribute to delayed S-phase onset in E1-/- 
mice.  
 
Fig.11: Analysis of RB phosphorylation and E2F1 expression. 
(A) Whole liver cell extracts were investigated for RB phosphorylation.Two distinct signals for 
phospho-RB representing phosphorylated and hyper-phosphorylated RB were detected and 
highlighted by arrows. The expression levels of total RB and GAPDH are presented as internal 
loading controls. (B) Kinetics of E2F1 gene expression 0-48 h post PH measured by quantitative 
real-time PCR. The average of five independent experiments is shown.  
 
In contrast, E2-/- mice displayed strong RB hyper-phosphorylation 
beginning 24 h post PH (Fig. 11 A) and average cdk2 kinase activity appeared 
to be significantly stronger compared to WT or E1-/- mice. In parallel, E2F1 
expression was slightly prolonged compared to controls suggesting that earlier 
onset of S-phase in E2-/- livers might be directly regulated by accelerated cdk2 
kinase formation, whereas the prolonged S-Phase could in addition be 
attributed to prolonged E2F expression.  
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 3.2 Altered S-phase initiation in E1-/- - and E2-/- mice 
correlates with aberrant expression of cyclin E1, cyclin E2 and 
p27   
 
In liver regeneration after PH, the checkpoint cyclin D1 is directly 
activated by mitogenic factors such as NF-κB and Jun/AP1 (Guttridge et al., 
1999; Schwabe et al., 2003) eventually leading to activation of Cyclin E/cdk2 
and subsequent G1/S-phase transition. In order to check, whether the priming 
phase of liver regeneration in hepatocytes is already different in WT-, E1-/- - and 
E2-/- mice, cyclin D1 expression after PH in these animals was analysed (Fig. 
12). In all animals investigated, first appearance of cyclin D1 expression was at 
36 h after PH irrespective of the cyclin E genotype and the expression profile 
was similar in all three groups demonstrating that the differences seen in S-
phase initiation are cyclin D - independent.  
 
 
 
 
 
 
 
 
 
 
Fig.12: Liver protein extract (30 µg) of were isolated at indicated time points after PH from 
WT, E1-/- and E2-/- mice and subjected to Western blot analyzes using antibodies for 
detection of cyclin D1. GAPDH expression was used as loading control. 
 
Next, the expression pattern of E-cyclins in all mouse strains after PH 
was analysed. In WT mice, cyclin E1 protein expression was limited to a time 
frame of 40h-48h following PH with the maximum 48h after surgery (Fig 13, 
upper panel). In contrast, E2-/- mice displayed almost continuous cyclin E1 
expression from 24h-96h, with strongest expression from 24h-72h after PH. 
This indicates that cyclin E2 depletion may lead to prolonged cyclin E1 
expression in the course of liver regeneration which was also clearly correlated 
with the prolonged cyclin E/cdk2 kinase activity in E2-/- mice (Fig. 9).  
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Fig.13: Liver protein extract (30 µg) were isolated at indicated time points after PH from 
WT, E1-/- and E2-/- mice and subjected to Western blot analyzes using antibodies for 
detection of cyclin E1. GAPDH expression was used as loading control. 
 
 Among many antibodies tested, no commercial antibody was available 
specifically detecting the murine cyclin E2 protein in immunoblots. Thus, cyclin 
E1 and E2 expression was measured on the mRNA level in all mouse strains by 
quantitative real-time PCR. 
In WT mice following PH an almost identical mRNA expression pattern of 
cyclin E1  and E2 was observed with a single peak of approximately 25fold 
expression 40 h after surgery compared to untreated animals (compare Fig. 14 
A and B). Hence, maximum expression of cyclin E1/E2 mRNA correlates with 
the maximum of cyclin E1 protein expression and may serve as an additional 
marker to study the regulation of E-cyclins.  
 
 
 
 
 
 
W
T
GAPDH
GAPDH
cyclin E1
E2
-/-
time after PH (h)
0 24 36 40 48 72 84 96 168
cyclin E1
3. Results                                                                                                          43 
 
 
Fig.14: Relative real-time-PCR analysis of the indicated genes measured in the liver at 
various time points after PH in E1-/-, E2-/- and control mice (WT). 
The expression levels at all time points were normalized to GAPDH expression and 
calculated as fold induction in comparison to untreated animals of the same cohort. (A) 
mRNA expression profile of cyclin E2 in E1-/- mice and WT controls. (B) Gene expression 
profile of cyclin E1 in E2-/- - and WT mice. 
 
 
In order to quantitatively compare the expression levels of cyclin E1 and 
cyclin E2, an absolute measurement of cyclin E1 and E2 using standard curves 
for both molecules  was also performed (Fig. 15). Interestingly, already the 
basal expression of cyclin E2 in untreated mice was approximately 10fold 
higher compared to cyclin E1 expression and in the course of liver regeneration 
the number of cyclin E2 mRNA molecules always exceeds cyclin E1 between 2-
10 fold.  
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Fig.15: Absolute measurement of cyclin E1 and E2 mRNA level in WT mice. The absolute 
number of cyclin E1 and E2 molecules was measured using standard curves and 
normalization to GAPDH expression as indicated on the y-axis. 
 
Next, cyclin E2 mRNA expression in WT  and E1-/- mice was compared 
(Fig. 14 A). Interestingly, significantly lower levels of cyclin E2 in E1-/- mice were 
detected for all investigated time points in comparison to WT animals. This 
implicates that cyclin E1 may positively regulate cyclin E2 gene expression in 
liver regeneration. Of notice, E1-/- mice do not show any induction of cyclin E2 
gene expression within the first 36 hours after PH which fits to the delayed 
expression of PCNA shown in Fig. 8 B.  
In contrast, E2-/- mice expressed more cyclin E1 m-RNA compared to WT 
controls especially between 40 h and 72 h after PH (Fig. 14 B). Of notice, this is 
consistent with the time frame of increased cdk2 kinase activity in these animals 
(compare Fig. 9) thereby implicating that increased cyclin E1 expression in E2-/- 
mice contributes to prolonged cdk2 kinase activity and enhanced S-phase 
initiation 
Many studies demonstrated that the activity of cyclin E/cdk2 complexes 
might be negatively regulated by CDK-inhibitory proteins of the Cip/Kip family 
such as p21 and p27 (Albrecht et al., 1998). Therefore p21 and p27 protein 
expression were investigated in the course of liver regeneration in WT-, E1-/- - 
and E2-/- mice. 
During liver regeneration in WT mice following PH, p27 is continously 
expressed and only slightly up-regulated at the peak of DNA synthesis (Fig. 16, 
upper panel), which is consistent with earlier studies. (Albrecht et al.,1998). A 
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similar expression profile was also found in E1-/- animals, although a significant 
down-regulation 72 h after PH was evident correlating with prolonged cdk2 
kinase activity at this time point. Importantly, depletion of Cyclin E2 resulted in a 
strong down-regulation of p27 expression in both quiescent livers and 
throughout the whole time course of liver regeneration (Fig. 16, upper panel), 
thereby potentially contributing to accelerated and prolonged S-phase 
progression.  
In WT mice, p21 is tightly regulated during liver regeneration with two 
peaks at 36 h and 72 h, respectively (Fig. 16, middle panel). Although E1-/- and 
E2-/- mice also showed a regulated p21 expression, no p21 was detected 72 h 
after PH in both strains which correlated with absence of p27 and exceeding 
cdk2 activity at this time point. 
Fig.16: Whole liver cell extracts were investigated for the expression of cell cycle 
inhibitors p27 and p21. The expression levels of GAPDH are presented as internal 
loading controls. 
 
 
 
 
 
time after PH (h)
0 24 36 48 0 24 36 48 0 24 36 4872 72 72
p21
p27 
GAPDH
E1-/- E2-/-WT
3. Results                                                                                                          46 
  
 3.3 Kinetics of DNA synthesis differs in E2-/- and E2-/- mice  
 
All previous experiments indicated that depletion of cyclin E1 delays S-
phase entry as measured by onset of PCNA expression and cdk2 kinase 
activity, whereas cyclin E2 ablation accelerates G1/S-phase transition. Next, S-
phase progression in E1-/- and E2-/- mice was studied by measuring in vivo 
incorporation of the thymidine analogue Bromodeoxyuridine (BrdU) into DNA 
following PH.  
In WT mice, the first hepatocytes showing BrdU incorporation were 
detected 36 h after PH (Fig. 17, A left panel and B). Maximum numbers of 
hepatocytes in S-phase were found between 40 h and 48 h (26% and 21%, 
respectively) after surgery (Fig. 17 B). This was correlated with a maximum 
gene expression of the S-phase marker cyclin A2 at 40 h after PH (Fig. 18 A) 
and detectable cyclin A2 protein expression between 40 h and 48 h (Fig. 18 B). 
At later time points (72 h-168 h) the number of BrdU positive cells continuously 
decreased, and cyclin A expression was no longer detectable, indicating 
termination of S-phase.  
Hepatocytes of E1-/- mice showed retarded S-phase progression starting 
40 h after PH (Fig. 17, A medium panel and B),  which was consistent with a 
shift of the S-phase peak to 48 h but a significantly higher level of BrdU positive 
cells at that time point. Cyclin A2 mRNA expression was detectable from 40 h-
72 h after PH in these animals (Fig. 18 A). Most strikingly, maximum gene 
expression was found not until 72 h and consistent with that, E1-/- mice 
displayed a prolonged cyclin A2 protein expression from 40 h-72 h compared to 
the WT group (Fig. 18 B). Altogether these findings show that cyclin E1-/- mice 
perform a slightly delayed S-phase progression at the beginning of liver 
regeneration which is then compensated by a prolonged S-phase driven by an 
extended cyclin A expression. 
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Fig. 17: Immunhistochemical staining of BrdU incorporation in liver cryosections from 
WT, E1-/- and E2-/- mice 36 h and 40 h after PH. Representative tissue sections from a 
minimum of 5 animals per time point are shown. Black arrows indicate nuclei with BrdU 
incorporation. Quantification of BrdU-positive hepatocyte nuclei at indicated time points 
from 0 h to 168 h after PH in E1-/- and WT mice (B) or in  E2-/- and WT mice (C) are shown. 
The data was calculated as percentage of BrdU-positive nuclei per magnification field. 
Each value represents the mean of 5-10 mice. (*) p < 0.02. 
 
In contrast E2-/- mice showed a completely different pattern of S-phase 
progression during liver regeneration. At the time point of S-phase entry (36 h 
post PH) E2-/- mice already have significantly more hepatocytes in S-phase 
(12.5%) compared to the WT group (6.7%, Fig. 17 A and C). Further analysis 
revealed that for the majority of time points investigated (except 84 h and 168 h 
post PH) the livers of E2-/- mice display a higher number of hepatocytes in S-
phase compared to WT animals indicating excessive DNA-synthesis in these 
mice .  
Cyclin A gene expression was prolonged and in overall higher as in 
controls (Fig. 18 A). Of notice, Cyclin A2 protein expression in E2-/- mice 
peaked at the maximum of S-phase progression as expected (40 h-48 h). 
However, a basal Cyclin A2 expression was detected at all time points in these 
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animals, which was not observed in WT or E1-/- mice and might contribute to the 
strong DNA synthesis in E2-/- mice (Fig. 18 B).  
 
 
 
 
 
 
 
 
Fig. 18: Protein extracts and mRNA were isolated at indicated time points after PH from 
livers of E1-/-, E2-/- and WT mice. (A) Analysis of cyclin A2 gene expression was 
performed via relative real-time PCR. The expression values were normalized to GAPDH 
expression and calculated as fold induction in comparison to untreated controls at 0 h. 
(B) Western blot analysis of cyclin A expression in E1-/-, E2-/- and WT control mice at 
indicated time points after PH. As internal loading control, GAPDH expression is shown. 
 
 
 3.3 Ectopic over-expression of cyclin E1 or E2 changes the 
cell cycle progression in the regenerating liver 
 
Previous data indicated that cyclin E2 might also have antagonist 
properties for cell cycle progression. To support this hypothesis, a recombinant 
adenovirus expressing murine cyclin E2 under the control of the CMV-promoter 
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(adv-CcnE2) was generated. As control, an adenovirus expressing luciferase 
was used (adv-Luc). WT - and E2-/- mice were injected with these adenoviruses 
followed by PH 24 h after virus application. E2-/- mice were sacrificed 36 h after 
PH (strongest difference in S-phase compared to WT), whereas WT mice were 
investigated at the peak of S-phase (48 h after surgery). Serum transaminases 
demonstrated only mild toxicity after adenovirus delivery to the liver (data not 
shown). Semi-quantitative RT-PCR revealed cyclin E2 expression in 
adenovirus-treated E2-/- mice following PH indicating adenoviral transduction 
(Fig. 19A). In adv-CcnE2 transduced WT mice, cyclin E2 signals were slightly 
stronger compared to control animals 48 h after PH (Fig. 19B).  
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Fig. 19: Semi-quantitative reverse-transcription PCR for cyclin E2 from total RNA of (A) 
E2-/- mice and (B) WT controls. Cyclin E2 expression in adv-CcnE2 transduced animals is 
indicated by an arrow. GAPDH expression is shown as internal control 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20 Quantitative measurement of cyclin E2 cDNA molecules in WT – and E2-/- mice 
following adv-CcnE2 transduction and PH. Cyclin E2 gene expression was calculated as 
number of molecules/106 GAPDH. 
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Absolute quantification revealed that adenovirus delivery induced an 
approximately 2fold increase of cyclin E2 mRNA expression in WT mice after 
PH. In E2-/- mice, adv- CcnE2 induced cyclin E2 expression was comparable to 
WT baseline levels (Fig. 20). This is explained by moderate gene delivery via 
adv-CcnE2 showing a gradient with most efficient levels in close proximity to 
portal venules and less evident in peripheral regions (Fig.21). 
 
 
 
 
 
 
Fig. 21: Determination of adv-CcnE2 transduction efficiency. Liver cryosections of non-
transduced (ctrl) or adv-CcnE2 injected (CcnE2) WT mice were sacrificed 48 h after PH 
and stained with an antibody directed against the adenoviral E1A protein and subjected 
to immunofluorescence microscopy. Adenoviral transduced hepatocytes are indicated 
by green staining. 
 
The impact of ectopic cyclin E2 expression was determined by 
measuring BrdU incorporation. As expected, adv-Luc treated E2-/- mice showed 
stronger S-phase activity compared to WT controls, but similar BrdU 
incorporation compared to non-transduced E2-/- animals (Fig. 22 A) proving that 
mild virus transduction per se did not affect cell cycle progression. However, 
adv-CcnE2 delivery significantly reduced the number of E2-/- hepatocytes in S-
phase from 10.8% to 3.8% supporting the hypothesis that cyclin E2 has 
antagonistic effects on S-phase entry. Accordingly, adenoviral cyclin E2 
expression reduced S-phase activity in WT mice from 19.5% to 10.6% (Fig. 22 
B). Of notice, in periportal hepatocytes with highest adenovirus transduction 
BrdU incorporation was minimal (see Fig. 21). 
 
 
 
 
CcnE2ctrl
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Fig. 22: Determination of BrdU incorporation in E2-/- and WT mice after PH transduced 
with either adv-Luc (Luc) or adv-CcnE2 (CcnE2). (A). Immunofluorescence staining of 
BrdU incorporation in liver cryosections from WT and E2-/- mice 36 h and 40 h after PH. 
(B). The percentage of BrdU positive hepatocytes from three independent experiments is 
shown. (*) p < 0.01; (#) p < 0.05.  
 
 
In a second approach, WT mice were transduced with adv-CcnE1 and analyzed 
before- and after PH (strongest effect of Cyclin E2 depletion on DNA synthesis 
compared to WT). As control, an adenovirus expressing luciferase was used 
(adv-Luc). WT mice were injected into tail vein with adenoviruses and subjected 
to PH 24 h after virus application. 
Relative RT-PCR revealed that in quiescent livers, adenoviral Cyclin E1 
delivery already resulted in a 10fold up-regulation of Cyclin E1 mRNA 
expression which further increased during liver regeneration (Fig. 23 A). 
The influence of ectopic cyclin E1 over-expression on hepatocytes proliferation 
in WT animals was identified by BrdU staining (Fig. 23 B).  
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Fig. 23: Ectopic over-expression of Cyclin E1 in hepatocytes after PH.  
 
(A). WT mice were transduced with adv-CcnE1 (Cyclin E1) or adv-Luc (Luc) where 
indicated. Cyclin E1 cDNA was measured in virus-transduced and mock-treated mice 
before – and 36 h after PH. 
(B).  Determination of BrdU incorporation following adenoviral over-expression of Cyclin 
E2 in WT - and E2-/- mice (green staining) or Cyclin E1  in WT animals (red staining) for 
time points post PH as indicated. Total nuclei are stained in blue with DAPI. As control, 
animals were transduced with adv-Luc (Luc). For each group a minimum of three animals 
was analyzed and quantitative data of five cryosections per animal is shown in the right 
part of the panel. (*) p < 0.01; (#) p < 0.05. 
 
In consistency with previous data, adv-Luc treated mice 36h after PH 
shown only slight increase of proliferation (3.1% BrdU-positive cells) (Fig. 23 
B). 
In sharp contrast, ectopic over-expression of Cyclin E1 in WT animals 
resulted in substantial higher DNA-synthesis (8.9% BrdU-positive cells, Fig 
23B). 
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Taken together these data indicate that over-expression of Cyclin E1 
induce S-phase progression in WT hepatocytes after PH and reflects the 
accelerated onset of S-phase found in E2-/- animals.  
 3.4 Increased DNA-synthesis in E2-/- mice results in 
augmented liver mass and improved survival in a model of fatal 
liver failure 
 
Liver regeneration following PH in mice is characterized by 1-2 rounds of 
DNA replication in the remnant hepatocytes and compensatory hyperplasia of 
the remaining liver usually leading to full restoration of the original liver mass 
approximately 168 h after surgery (Fausto et al., 2006).   
To investigate the physiological consequences of the earlier onset of S-
phase entry and amplified DNA synthesis, the efficiency of liver regeneration in 
WT, E1-/- and E2-/- mice was compared by determining the liver weight/body 
weight ratio of the remnant liver at different time points after liver resection. Of 
notice, untreated E2-/- mice displayed a slightly reduced relative liver mass, but 
24 h after PH any differences in the liver weight index between the three groups 
was not found (Fig. 24). However, seven days after PH the liver mass in E2-/- 
animals was 44% higher compared to WT mice (5.2% of body weight compared 
to 3.6% in WT animals, Fig. 24).  
 
Fig. 24: At indicated time points after PH, the remnant livers were extracted and the liver 
weight index was calculated as the liver weight/body weight ratio in percent 
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This was accompanied by a macroscopically visible increase of liver size 
(Fig. 25) suggesting that cyclin E2 depletion leads to de-regulated hepatocyte 
growth resulting in hepatomegaly. However, two weeks and four weeks after PH 
the liver weight index in these animals did not further increase (data not shown) 
indicating that the liver regeneration process in E2-/- mice is also terminated 
although at a later time point.  
 
 
 
 
 
 
Fig. 25: Representative livers from WT, E1-/- and E2-/- mice 168 h after PH are shown. 
Regenerated livers from E2-/- mice show macroscopically visible increase in size and 
mass. 
 
To further analyze the effects of accelerated onset of S-phase in E2-/- 
mice, the model of fatal hepatic failure following 90% hepatectomy was applied 
to these animals. During this procedure, 100% of WT animals died within 24 h 
due to acute liver failure (Fig. 26). In contrast, at this time point 80% of the E2-/- 
mice were still alive and the majority of the animals died not before 40 h after 
liver resection although eventually none of the mice survived this treatment. 
This argues that the accelerated and stronger start of DNA synthesis in E2-/- 
mice might result in a better prognosis after fatal liver injury probably due to 
improved metabolic capacity in the remnant liver. 
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Fig. 26: Depletion of cyclin E2 provides improved survival after 90% hepatectomy. 
Kaplan-Meyer survival curve shows time-dependent survival of WT mice (broken line, 
n=5) and E2-/- mice (solid line, n=5).  
 
 
 3.5 Amplified DNA synthesis in E2-/- mice is not correlated 
with increased mitotic activity 
The next aim was to understand the cellular mechanisms underlying the 
observed hepatomegaly in E2-/- mice following PH. Increased DNA synthesis 
might directly result in stronger mitotic activity of hepatocytes and in order to 
test this hypothesis, the number of mitotic cells in the course of liver 
regeneration was first investigated by measuring histone H3 phosphorylation in 
situ. Histone H3 phosphorylation at serine 10 is closely correlated with mitotic 
chromosome condensation and serves as a marker for early mitosis (Hans and 
Dimitrov, 2001).  
As expected, histone H3 phosphorylation was undetectable in quiescent 
livers of WT, E1-/- and E2-/- mice. In WT animals the first appearance of mitotic 
cells was observed 36 h after PH and mitosis reached its maximum 48 h after 
surgery (Fig. 27 A, B). Of notice, in these animals a second peak of H3 
phosphorylation was detected at 84 h after PH (Fig. 27 A, B) which is 
consistent with the finding, that normal hepatocytes undergo two rounds of 
mitosis following PH (Trembley et al., 1996). Accordingly, the gene expression 
profile of cyclin B1, which served as an additional mitosis marker, was also 
biphasic with expression maxima at 48 h and 84 h after PH (Fig. 28 A) and the 
corresponding protein expression was evident at comparable time points (Fig. 
28 B). 
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Fig. 27: Liver cryosections from WT, E1-/- and E2-/- mice at time points after PH as 
indicated were analysed for phosphorylation of histone H3 at Ser10 using 
immunofluorescence microscopy. (A) Representative images at relevant time points are 
shown. Total nuclei are counterstained with DAPI (blue); green nuclei indicate H3 
phosphorylation. (B, C) Calculation of histone H3-positive nuclei (presented in 
percentage) in liver sections following PH from WT and E1-/- mice (B) and WT and E2-/- 
mice (C). Each value represents the mean of 5-10 animals. 
 
E1-/- mice revealed a strong mitotic activity between 40 h and 48 h after 
surgery, but showed significantly reduced mitosis at all other time points 
compared to WT controls (Fig. 27 B). In particular, these animals lacked a 
second wave of mitosis as also evidenced by diminished cyclin B mRNA - and 
protein expression (Fig. 28 A-B) indicating that cyclin E1 ablation negatively 
affects hepatocyte mitosis.  
Surprisingly, no significant difference of the H3 phosphorylation pattern 
was detected in E2-/- mice compared to controls except that also E2-/- mice 
lacked the second round of mitotic activity which was found in WT mice (Fig. 27 
A, C). Cyclin B protein expression was detectable between 36 h-48 h at a level 
comparable to controls (Fig. 28 A-B). These findings were completely 
unexpected and suggest that the accelerated and amplified DNA synthesis 
found in E2-/- mice does not initiate significantly more mitosis in the course of 
liver regeneration. 
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Fig. 28: (A) Kinetics of cyclin B mRNA expression in response to PH at indicated time 
points in E1-/-, E2-/- and WT mice. The expression values were normalized to GAPDH 
expression and calculated as fold induction in comparison to untreated controls at 0 h. 
(B) Analysis of cyclin B protein expression in E1-/-, E2-/- and control mice (WT) between 0 
h and 168 h after PH. GAPDH expression is indicated as internal standard. 
 
 3.6 Cyclin E1 and cyclin E2 provide complementary 
functions for endoreplication in hepatocytes after PH 
 
E2-/- mice did not show increased mitotic activity after PH although they 
performed stronger DNA synthesis and developed hepatomegaly. To explain 
this unexpected phenomenon, the replicated DNA in the regenerating 
hepatocytes was tracked down by FACS analysis in subsequent experiments.  
Following PH in WT, E1-/- and E2-/- animals, primary hepatocytes were 
isolated from these mice at 0 h (untreated controls), 48 h (maximum of S-
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phase), 72 h (late regeneration phase) and 96 h (termination of liver 
regeneration) and then subjected to FACS analysis after propidiumiodid 
staining. The cell populations were analysed by their DNA content and 
classified as diploid (2n), tetraploid (4n) and higher polyploid (>4n) hepatocytes 
(Fig. 29 A-D). 
In untreated mice (Fig. 29 A) no major differences were found in the 
distribution of polyploid hepatocytes in all three groups and in all livers the 
majority of hepatocytes turned out to be higher than 4n, which indicated that E-
cyclins are not essential for promoting polyploidy in the course of liver 
development. At 48 h after PH first differences in the DNA distribution were 
observed between WT mice on the one hand and E1-/- and E2-/- mice on the 
other hand (Fig. 29 B). However, as these mice are still in S-phase progression, 
this rather reflects differences in DNA synthesis efficiency between the three 
strains. During the late phase of liver regeneration (72 h) the distribution of >4n 
hepatocytes in WT - and E2-/- mice was similar (approximately 58%), whereas in 
E1-/- mice the number of >4n hepatocytes was strongly reduced to 23% (Fig. 29 
C) suggesting an impact of cyclin E1 depletion on DNA synthesis or 
endoreplication.  
 Of special interest was the analysis of hepatocytes 96 h after PH when 
liver regeneration and S-phase were thought to be terminated. In WT controls, 
only a minor subpopulation of hepatocytes (24%) turned out to be diploid after 
termination of liver regeneration, whereas the majority of cells were tetraploid 
(40%) or >4n (36%). This result was not unexpected as hepatocytes usually 
maintain high polyploidy due to their strong metabolic activity (Gupta, 2000) and 
it has been reported earlier that the polyploidy further increases after PH (Sigal 
et al., 1999). However, in E1-/- mice a different distribution was found as the 
majority of hepatocytes (45%) was shown to be diploid whereas only a small 
subpopulation (25%) was more than tetraploid (Fig. 29 D , E). 
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Fig. 29: Primary hepatocytes from E1-/-, E2-/- and WT mice were isolated before and at 
different time points after PH. DNA content of propidium iodide (PI) stained hepatocytes 
was determined by FACS analysis. The diagrams show the distribution of diploid (2n), 
tetraploid (4n) and hyperploid (>4n) hepatocytes from three independent experiments as 
percentage of viable cells. (A) Quiescent hepatocytes from untreated mice. (B) 
Hepatocytes 48 h post PH (C) 72 h post PH; (D) 96 h hours post PH. (E) Representative 
FACS histograms for WT, E1-/- and E2-/- hepatocytes isolated 96 h after PH. On the x-axis 
the intensity of PI per cell is shown; the y-axis indicates the number of cells showing a 
distinct PI intensity; gates were set for 2n, 4n and more than 4n hepatocytes excluding 
the apoptotic cell fraction. 
 
In complete contrast to these findings, E2-/- hepatocytes were highly 
polyploid 96 h after pH with more than 60% of cells showing a ploidy >4n (Fig. 
29 D , E, right panel).  
 The conclusion from this data is that E1-/- hepatocytes have a defect in 
endoreplication during liver regeneration, whereas the excessive synthesized 
DNA found in E2-/- livers following PH could be tracked down in highly polyploid 
hepatocytes. 
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With FACS analysis, entire hepatocytes were sorted and investigated. 
Therefore, with this method binuclear cells (which may develop from nuclear 
division without cytokinesis) cannot be differentiated from mononuclear cells of 
higher ploidy (as a result of endoreplication). To further investigate, if E1-/- and 
E2-/- hepatocytes are really affected in endoreplication we next isolated primary 
hepatocytes from male mice 96 h after PH and subjected them to FISH analysis 
using a specific probe for the Y chromosome.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30: Hepatocyte ploidy in nuclei of primary hepatocytes 96 h after partial hepatectomy 
was measured by FISH technique. Males WT, E1-/- and E2-/- mice were subjected to PH. 96 
h after surgery, primary hepatocytes were isolated and probed for the Y chromosome 
(Cy3, red signals). (A) WT hepatocytes. (B) E1-/- hepatocytes. (C) E2-/- hepatocytes. (D) 
Quantification of polyploidy in primary hepatocytes from WT, E1-/- and E2-/- mice 96 h 
post PH. For each group, a minimum of 1000 nuclei were analyzed for the number of Y 
chromosomes. The data was calculated as the percentage of 2n, 4n and >4n nuclei per 
population. Significance was calculated according to student’s t-test.  
 
In WT cells, the majority of nuclei (approximately 70%) turned out to be 
diploid (Fig. 30 A, D) and only minor subpopulations (26.2%) were tetraploid or 
octoploid and higher (7%).  This is not necessarily in contrast to our FACS data 
(Fig. 29 E) but reflects the fact, that WT hepatocytes are frequently binuclear 
(Mossin et al., 1994; Wheatley, 1972).  
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 Most strikingly, 90% of nuclei from E1-/- hepatocytes were only diploid 
(Fig. 30 B, D) supporting our hypothesis that E1-/- hepatocytes are defect for 
efficient endoreplication. On the contrary, E2-/- hepatocytes showed an equal 
distribution of diploid, tetraploid and higher polyploid nuclei (Fig. 30 C, D) 
eventually reflecting overall higher polyploidy in E2-/- cells. This data 
demonstrates that cyclin E1 is critical for restoring polyploidy after liver 
regeneration, whereas cyclin E2 is antagonizing this effect.  
In addition, the FISH experiment revealed a direct correlation between 
the ploidy of a nucleus and its respective size revealing predominantly large 
nuclei in polyploid E2-/- hepatocytes (Fig. 30 C) which might contribute to 
increased liver mass and hepatomegaly as found in these animals. 
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 3.7 Role of E-type cyclins in liver  fibrogenesis 
3.7.1 Over-expression of c-myc in hepatocytes induces liver fibrosis 
in a cyclin E1 dependent manner 
Hepatocyte specific alb-myc transgenic animals (alb-myctg) have been 
intensivly investigated for their potential to develop hepatocellular carcinomas 
(Calvisi and Thorgeirsson, 2005). However, the early molecular and cellular 
changes in the respecting livers leading to inaccurate gene regulation or 
pathological stages such as liver fibrosis and cirrhosis have not been unveiled. 
Therefore, as a part of this study, early and time dependent molecular events in 
alb-myc transgenic livers were investigated in order to specifically address 
changes in gene regulation related to cyclin E1 and E2. 
 In alb-myctg mice (Fig. 31 A) an age dependent increase of the cyclin E1 
mRNA expression was detected, which indicate a correlation of cyclin E1 levels 
and the liver pathogenesis as old mice are highly predisposed to HCC 
development. In contrast, cyclin E2 expression was down-regulated with an 
age-dependent tendency (Fig. 31 B). 
 
 
 
 
 
 
 
 
 
 
Fig. 31: Time dependent expression of cyclin E1 (A) and E2 (B) by quantative real time 
PCR. 
Kinetics of cyclin E1 and E2 mRNA expression in alb-myctg mice at the age of 9, 20 and 
58 weeks. The expression values were normalized to GAPDH expression and calculated 
as fold induction in comparison to Wt controls at 0 h. 
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The human pathogenesis leading to the development of hepatocellular 
carcinoma is mostly induced by a chronic liver injury and inflammation and 
progresses from liver fibrosis to cirrhosis further resulting in tumor formation. To 
test, whether HCC development in alb-myctg mice is also preceeded by liver 
fibrosis and if this might be dependent on Cyclin E1 or E2 expression, 
Cryosections from 40 week old WT, alb-myctg , or E1-/- alb-myctg and E2-/- alb-
myctg mice, respectively, were stained with an collagen I antibody and analysed 
using immunofluorescent microscopy (Fig. 32). As expected, in WT mice 
collagen I expression was limited to liver vessels. Interestingly, in alb-myctg 
mice increased collagen deposition in the liver with fiber formation was 
observed. When Cyclin E1 was depleted in these animals, collagen deposition 
was reduced to almost WT background levels, whereas knocking down Cyclin 
E2 in alb-myctg mice resulted in even stronger collagen expression and fiber 
formation (Fig. 32).  
 
 
 
 
Fig.32: Representative collagen I immunofluorescence at the age of 40 weeks in WT, alb-
myctg, E1-/- alb-myctg, E2-/- alb-myctg mice. Fibrillar collagen deposition (red fibers) is 
detected in alb-myctg mice, significantly ruduced in E1-/- mice and strongly increased in 
E2-/-. 
 
 
These findings were further investigated by performing western blot 
analysis of collagen I protein expression from livers of WT, alb-myctg , E1-/- alb-
myctg and E2-/- alb-myctg mice at the age of 20 and 40 weeks, respectively (Fig. 
33), thereby confirming that collagen I expression in alb-myctg mice  is clearly 
increased in comparison to WT animals, which is dependent on cyclin E1 
expression and antagonized by cyclin E2. 
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Fig. 33: Western blot analysis of collagen I expression in alb-myctg, alb-myctg/ E1-/-, alb-
myctg/ E2-/- and WT control mice at the age of 20 and 40 weeks, respectively.  As internal 
loading control, GAPDH expression is shown. 
 
These results indicated for the first time, that over-expression of c-myc in 
the liver is not only related to hepatocarcinogenesis, but also to fibrogenesis in 
a cyclin E1/E2 dependent manner leading to the current hypothesis that c-myc 
and cyclin E1 are pro-fibrotic factors whereas cyclin E2 potentially antagonizes 
fibrosis.  
Liver fibrogenesis requires chronic liver injury. To further elucidate the 
mechanisms leading to c-myc dependent fibrogenesis, TUNEL assays and 
phospho-histone H3 stainings were performed in liver cryosections from alb-
myctg mice at different age between 9-40 weeks. One representative example is 
shown in Fig. 34. Hepatocyte-specific c-myc-transgenic mice showed 
spontaneous apoptosis with a frequency of approximately 1-2% of all 
hepatocytes independent of age (Fig. 34A), which was correlated with a 
compensatory proliferation of the same frequency as shown by increased 
number of phospho-histone H3 positive hepatocytes indicating mitosis (Fig. 
34B).  
This continous apoptosis and subsequent compensatory proliferation in 
alb-myctg reflects a scenario which is very similar to a mild chronic liver injury 
and might contribute to the liver fibrosis observed in these animals. 
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Fig. 34: Representative liver cryosections from alb-myctg mice (40 weeks old) were 
analysed for apoptosis (TUNEL assay) (A) and phosphorylation of histone H3 at Ser10 (B) 
using immunofluorescence microscopy. Spontaneous apoptosis and proliferation are 
detected in alb-myctg mice compare to WT controls. 
 
 3.7.2 Cyclin E1 is an essential pro-fibrotic factor in the liver 
The previous results indicated that Cyclin E1 expression is related to liver 
fibrogenesis in alb-myctg mice which is potentially antagonized by cyclin E2. 
However, as over-expression of c-myc in the liver is not an established animal 
model for liver fibrosis so far, the further aim of this study was to evaluate the 
pro-fibrotic function of cyclin E1 in a well accepted model of liver fibrosis. 
Therefore, cyclin E1-/- and E2-/- mice were furter characterized in the animal 
model of carbon tetrachloride (CCL4)- induced liver fibrosis.  
WT, E1-/- and E2-/- mice were treated with CCl4 (0.6 ml/kg body weight in 
olive oil i.p., twice per week). After 4 weeks of treatment, mice were sacrificed 
and the progression of liver fibrosis was quantified. As shown in Picrosirius red-
stainined sections, repeated injections of CCL4 for 4 weeks induced prominent 
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fibrosis associated with septum formation in WT animals (Fig. 35 A), whereas in 
E1-/- mice, the extend of fibrosis was considerably reduced (Fig. 35 B). Of 
notice, there was no significant difference in septum formation between E2-/-  
and WT mice after 4 weeks of CCL4 application. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 35:  Picrosirius-red staining of CCL4 (4 weeks) induced hepatic fibrosis in WT  
(A)  E1-/-  (B) E2-/-  (C) mice. 
 
To explore the mechanism underlying the inhibition of liver fibrosis in E1-/- 
mice, additional markers of liver fibrogenesis were investigated. Expression of 
alpha-smooth muscle actin (α-SMA) is a marker for activated, proliferating 
hepatic stellate cells (HSC), which was investigated by immunostaining in 
cryosections from WT and E1-/- mice following 4 weeks of CCL4 application 
(Fig. 36 A-B). This experiment demonstrated that the number of α-SMA positive 
cells in E1-/- mice was significantly reduced compared to corresponding wild-
type controls 4 weeks after CCL4 treatment.  
Moreover, quantitative real-time PCR analysis of collagen I expression 
revealed  that – as expected, in WT animals following CCl4 treatment the 
collogen expression was strongly increased (20 times fold induction in 
E1 - / - WT 
E2 - / - 
A B 
C 
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comparison to untreated WT controls). In sharp contrast, E1-/- mice showed only 
a slight increase of collagen I expression (2 times higher compared to 
background expression, Fig. 36C) further demonstrating that inhibition of cyclin 
E1 protects from liver fibrosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 36: Deletion of cyclin E1 reduces HSC proliferation. (A) α-SMA positive HSCs were 
detected by Immunohistochemistry, (B) RT-PCR analysis of collagen I mRNA expression 
in response to CCL4 application (4 weeks) in E1-/- and WT mice. The expression values 
were normalized to GAPDH expression and calculated as fold induction in comparison to 
untreated controls. 
 
Concomitant with fibrosis progression in WT mice, the level of cyclin E1 
mRNA was slightly up-regulated in these animals 4 weeks after CCl4 treatment 
compared to untreated controls (Fig. 37A). As expected, no cyclin E1 
expression was detected in E1-/- mice, which served as a negative control (Fig. 
37A). 
In contrast, the expression of cyclin E2 was not changed in the WT group 
following CCl4 treatment (Fig. 37B). However, in E1-/- mice 4 weeks after CCL4 
administration, the expression of cyclin E2 was 2 times higher compared to WT 
controls (Fig. 37B) further supporting the idea, that cyclin E2 counteracts cyclin 
E1 and might have anti-fibrotic functions.  
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Fig. 37: Up-regulation of cyclin E1 level in WT mice after 4 weeks of CCL4 treatment.  
(A) Induction of cyclin E2 in E-/- mice after 4 weeks of  CCL4 treatment  
(B)Significance was calculated according to student’s t-test (p<0,05). 
3.7.3 Inhibition of Cyclin E2 accelerates the onset of liver 
fibrogenesis 
The previous experiments (see chapter 3.7.2) demonstrated that depletion 
of cyclin E2 had no significant effect on the stage of fibrosis after 4 weeks of 
CCL4 treatment (compare Fig. 35 A, C). However, during liver regeneration the 
inactivation of cyclin E2 had the most striking effects during the earliest steps of 
cell cycle initiation (compare Fig. 8, 17). Therefore, it was also investigated 
whether depletion of cyclin E2 might have an effect on the earliest steps of liver 
fibrogenesis. Accordingly, WT and E2-/- mice were treated with CCl4 (0,6 ml/kg 
body weight in olive oil i.p., twice per week) for a short time span. Two weeks 
after CCl4 treatment mice were sacrificed and progression of liver fibrosis was 
analyzed by measuring sirius red staining of tissue sections and collagen I and 
α-sma mRNA expression, respectively.  
The sirius-red staining revealed that two weeks of CCl4 treatment is not 
suffucient to induce relevant fibrosis or fiber formation in WT mice. In sharp 
contrast, E2-/- mice already showed clear signs of liver fibrosis with first septum 
formation (Fig. 38 B). This finding was supported by increased expression of 
both collagen I and α-sma RNA in these animals compared to the WT control 
group (Fig 39) suggesting that cyclin E2 depletion results in an earlier onset of 
liver fibrosis.  
A. 
 
B.
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Fig. 38: Depletion of cyclin E2 accelerates early stage liver fibrosis after 2 weeks of CCL4 
treatment. Picrosirius-red staining in WT (A), E2-/- (B) mice. 
 
 
 
 
 
 
 
 
 
Fig. 39: Changes in expression profile of collagen I (A) and α-SMA (B) m-RNA after 2 
weeks of CCL4 treatment in E2-/- and WT mice. 
The expression values were normalized to GAPDH expression and calculated as fold 
induction in comparison to untreated controls. Significance was calculated according to 
student’s t-test. 
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4. Discussion 
 4.1 Role of E-type cyclin during liver regeneration 
The expression of E-type cyclins sharply peaks at the G1/S restriction 
point of the cell cycle (Koff et al., 1992) and the canonical model of cell cycle 
regulation implicated that cyclin E/cdk2 kinase activity might be essential for S-
phase entry and subsequent cell cycle progression. Therefore, recent studies 
demonstrating normal development and cell cycle progression in mice either 
deficient for cyclin E1 or cyclin E2 were unexpected and implicated redundant 
mechanisms of cell cycle progression in higher eukaryotes (Geng et al., 2003).  
However, studies in E1-/-E2-/- embryos revealed an essential function of E-type 
cyclins in endoreplication of normally highly polyploid trophoblast giant cells 
(Geng et al., 2003; Parisi et al., 2003). Moreover, E1-/-E2-/- primary embryonic 
fibroblasts failed to re-enter the cell cycle after cell cycle arrest demonstrating 
an essential role of E-type cyclins for S-phase entry of quiescent cells.  
Liver regeneration following 2/3 liver resection in mice is a powerful 
experimental model for the study of the G0/G1-S-phase transition of 
predominantly quiescent hepatocytes. In the priming phase of liver 
regeneration, cytokines such as TNF, IL-6 and TGFβ drive the activation of 
mitogens and growth factors, which directly activate cyclin D/CDK4 and cyclin 
D/CDK6 complexes (Taub, 2004). It was shown that active cyclin D/cdk4/6 
kinases may phosphorylate the retinoblastoma protein Rb resulting in release of 
E2F transcription factors, subsequent transcription of cyclin E and formation of 
active cyclin E/cdk2 kinase which is believed to eventually drives the 
hepatocytes from late G1-phase into initiation of DNA synthesis.  
As the need of E-cyclins for S-phase entry has to be re-defined, the 
ultimate aim of this study was to re-evaluate the role of E-type cyclins for the 
G0/G1-S-phase transition during liver regeneration using the previously 
described constitutive knockout mice for cyclin E1 and cyclin E2. 
 
E1-/- mice display only marginal differences in cell cycle progression and 
show normal liver regeneration 
The present study revealed only a minimal effect of cyclin E1 depletion on 
the course of liver regeneration following PH. Although E1-/- mice displayed a 
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slight delay of S-phase entry, this effect was compensated by reinforced DNA 
synthesis at later time points eventually leading to normal liver mass restoration 
and liver function. This observation is in agreement with earlier studies showing 
that cyclin E1 is not essential for cell proliferation per se. Accordingly, it has to 
be postulated that other cyclins may compensate for loss of cyclin E1 function 
and potential candidates are cyclin E2 and cyclin A2. Studies directly 
addressing the function of cyclin E revealed that both cyclins may activate cdk2 
(Lauper et al., 1998) and are synchronously expressed during mouse 
development (Geng et al., 2001) implicating that cyclin E1 and cyclin E2 may 
provide redundant functions.  
Although the current study also shows an exactly identical expression 
profile of cyclin E1 and E2 during liver regeneration in WT mice, it seems to be 
rather unlikely that cyclin E2 predominantly compensates for loss of cyclin E1. 
First, cyclin E2 contributes only little to kinase activity in E1-/- mice during liver 
regeneration. Even more important, cyclin E2 gene expression is strongly down-
regulated in E1-/- mice implicating that cyclin E1 positively controls cyclin E2 
presumably via E2F transcription factors. It can be proposed that A-cyclins 
compensate for loss of cyclin E1 as the prolonged cyclin A protein expression 
as found in E1-/- mice perfectly matched with the obvious contribution of cyclin A 
for cdk2 kinase activity in these animals.  
 
Ablation of cyclin E2 up-regulates cyclin E1 expression and triggers 
excessive DNA synthesis during liver regeneration 
Based on the initial hypothesis that cyclin E1 and E2 may share redundant 
functions, present results using E2-/- mice were unexpected. After PH, E2-/- mice 
showed accelerated S-phase entry, persistent and strong DNA synthesis 
eventually leading to abnormal liver regeneration and hepatomegaly. This was 
associated with strong cdk2 kinase activity, higher and prolonged cyclin E1 and 
cyclin A2 expression and down-regulation of p27. 
 These data lead to the hypothesis that cyclin E2 is able to negatively 
control DNA synthesis by negatively regulating cyclin E1 expression thereby 
restricting cdk2 kinase activity. To test this hypothesis an adenovirus expressing 
cyclin E2 been constructed. Expression levels of extrinsic cyclin E2 were in the 
physiological range. Interestingly, in both WT and E2-/- mice the adv-CcnE2 
construct was able to block DNA synthesis. Therefore these results further 
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support initial findings and strengthened the hypothesis that at least in the liver 
cyclin E2 negatively controls DNA synthesis and thus has antagonistic functions 
compared to cyclin E1. 
Functionally, inhibition of DNA synthesis by cyclin E2 might be achieved on 
different levels. The experiments performed in the three mouse strains revealed 
that in E2-/- mice gene-expression and protein levels of cyclin E1 and A2 are 
strongly up-regulated, which correlates with increased DNA synthesis. This 
suggests a regulatory crosstalk between cyclins E1, E2 and A2 at the level of 
gene expression, where cyclin E2 is a negative regulator of cyclin E1 and A2. 
This concept is supported by the excessive cyclin E2/E1 mRNA expression ratio 
in WT mice which is strongest in quiescent livers (10:1) and weakest at the 
proliferation maximum (2:1). Hence, cyclin E2-/- livers express increased levels 
of cyclin E1 leading to stronger cyclin E1/cdk2 activity eventually explaining 
excessive S-phase progression. 
Therefore these results clearly suggest that cyclin E2 provides inhibitory 
functions on cyclin E1 and cell cycle progression in vivo although it cannot be 
exclude that these effects are limited to the regenerating liver.  
In this context antagonizing functions have recently also been described 
for the D-type cyclins D2 and D3 (Rojas et al., 2007). Hence, cyclin D2 and D3 
seem to play opposite roles in a model of tumor development with the ability of 
cyclin D3 to inhibit cyclin D2 expression which eventually leads to reduced cell 
growth in terms of tumor development. Consequently, the existence of several 
D- or E-type cyclins might not be relevant for functional redundancy but might 
be rather necessary to serve regulatory functions for ensuring proper cyclin 
activity.  
 
Pathophysiological consequences of dysregulated cyclin E activities 
Normal liver regeneration in E1-/- mice and full liver mass restoration 
occurred within the normal time frame of seven days, although this study 
indicated that liver regeneration in E1-/- mice was associated with slightly 
reduced mitosis. However, restoration of liver mass following PH can even 
occur without hepatocyte proliferation by hepatocyte hypertrophy (Minamishima 
et al., 2002). In conclusion, liver regeneration in E1-/- mice is the combined 
result of the slightly reduced hepatocyte proliferation and some hypertrophy.  
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In contrast aberrant liver regeneration was found in E2-/- mice associated 
with development of hepatomegaly within seven days. However, eventually liver 
regeneration was also terminated in E2-/- animals without further increase in 
liver mass two weeks and four weeks after PH, respectively. Hepatomegaly in 
E2-/- mice was related to excessive DNA synthesis, but not increased 
hepatocyte proliferation suggesting that liver mass was due to aberrant 
polyploidy. No indication was found that this phenotype might contribute to 
development of liver disease or impaired liver function. However, it can be 
suggested that E2-/- mice may develop a more severe phenotype in a model of 
chronic liver injury and hepatitis leading to continuous compensatory hepatocyte 
regeneration probably related to stepwise increase of liver mass and 
hyperploidy thereby potentially sensitizing the liver to tumor development. 
Further investigations in more clinical related models will be necessary to 
investigate this aspect. 
However, depletion of cyclin E2 clearly had some benefits in a model of 
hepatic liver failure following 90% hepatectomy. WT mice died within 24h 
following 90% hepatectomy as reported earlier (Makino et al., 2005)  from acute 
liver injury associated with hypoglycaemia, substantially increased blood 
ammonia levels and encephalopathy (Soto-Gutierrez et al., 2006) contributing 
to the fact that the liver is a detoxificating organ. Interestingly, E2-/- mice had an 
improved survival after 90% hepatectomy and perhaps the accelerated onset of 
DNA synthesis is responsible for this effect eventually leading to faster 
expression of metabolic enzymes and detoxification. This could be of potential 
interest for future therapeutic approaches e.g. by using cyclin E2 deficient 
hepatocytes for cell transplantation or bioartificial liver supports. 
 
Differential roles of cyclin E1 and cyclin E2 for the control of 
endoreplication in hepatocytes 
Endoreplication results from duplication of genomic DNA without 
subsequent cell division and is preferentially found in differentiated cells with 
high metabolic activity (Edgar and Orr-Weaver, 2001) such as salivary glands of 
Drosophila melanogaster (Rudkin, 1972), trophoblast giant cells in mammals 
(Barlow and Sherman, 1972) and- although to a lesser extend in hepatocytes. 
In the latter ones, multinucleation due to nuclear division lacking cytokinesis 
further increases the cellular DNA content (Gerlyng et al., 1993) and  it was 
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shown that partial 2/3 hepatectomy may further increase hepatic polyploidy 
(Sigal et al., 1999).  
Earlier studies demonstrated that E-type cyclins are indispensable for 
endoreplication in Drosophila salivary gland cells (Su and O'Farrell, 1998), 
mammalian trophoblast giant cells and megakaryocytes (Geng et al., 2003; 
Parisi et al., 2003) and it has been postulated that they might be essential for 
loading the Minichromosome Maintenance (MCM) complex onto DNA 
replication origins during this process (Su and O'Farrell, 1998). However, in 
these studies it was not discriminated between cyclin E1 and E2 as they were 
considered to be functional redundant. Cyclin E1 and E2 mediate non 
redundant and even antagonizing roles for endoreplication. In this scenario, 
cyclin E1 turns out to be the key player for mediating endoreplication and 
consequently, E1-/- hepatocytes show strongly reduced polyploidy following PH. 
In contrast E2-/- hepatocytes showed the opposing effect with highly increased 
DNA content of their nuclei. This observation is not contradictory to the recently 
observed defect for endoreplication in E1-/-E2-/- cells but rather reflects our 
finding that depletion of cyclin E2 up-regulates cyclin E1 activity thereby 
enhancing DNA replication. 
In conclusion, the evidence that E-type cyclins E1 and E2 perform 
different, non-redundant functions during liver regeneration and describe for the 
first time an individual phenotype for E2-/- mice apart from male sterility. As 
cyclin E2 negatively regulates E1 activity and S-phase progression, presented 
results may also have some relevance for further understanding of the 
mechanisms leading to tumorgenesis. 
 
4.2 Role of E-type cyclins during fibrogenesis 
Fibrosis, or scarring of the liver, is a wound-healing response to that 
engages a range of cell types and mediators to encapsulate liver injury. Alcohol 
consumption, viral hepatitis and non-alcoholic steatohepatis are 3 major causes 
of chronic liver injury, leading to liver fibrosis, cirrhosis and liver cancer 
(Friedman, 2008).  
Activation of resident quiescent hepatic stellate cells into proliferative, 
contractile and fibrogenic cells and their interaction with hepatocytes and 
Kupffer cells in liver injury remains a dominant theme driving the field. One 
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important aim of this study was to investigate the contribution of E-type cyclins 
for proliferation and differentiation of hepatic cells during fibrogenesis. 
 
Inverse role of cyclin E1 and E2 in c-myctg dependent liver fibrogenesis in 
mice 
The transcription factor c-myc is a prominent oncogene, but also a well-
known regulator of cyclin E which is over-expressed during fibrosis, cirrhosis 
and hepatocarcinogenesis (Obaya et al., 1999). 
In vitro evidence clearly shows that overexpression of c-myc in transgenic 
mice induces spontaneous apoptosis but also in parallel constant and 
spontaneous mitosis. This observation is in agreement with earlier studies that 
c-myc plays dual roles and induces not only cell cycle but also acts as activator 
of apoptosis (Prendergast, 1999). The constant balance between apoptosis and 
cell cycle progression found in c-myctg mice which resulted in a continous 
compensatory proliferation is comparable to similar effects during mild chronic 
liver injury.  Therefore, compensatory proliferation appears to have a critical role 
during myc-dependent fibrogenesis.  
It has been shown before that c-myc is a positive regulator of G1-specific 
CDKs and, in particular, of cyclin E/CDK2 complexes (Amati et al., 1998). It 
correlates with the finding of this present study, where age-dependent up-
regulation of cyclin E1 mRNA has been shown. In contrast, the cyclin E2 mRNA 
expression pattern revealed down-regulation with an age-dependent tendency. 
These findings are in good agreement with the overall conclusion of this study 
that cyclin E2 might also mediate cell cycle inhibitory functions. However, under 
conditions of c-myc overexpression, hepatocytes are involved in the continious 
cell cycle progression which correlates with increase of cyclin E1- and in 
contrast decrease of cyclin E2 expression. 
Expression of collagen 1 is a marker of fibrogenesis and has been found in 
c-myctg mice already at the age of 9 weeks. Interestingly, expression of collagen 
1 was significantly reduced in E1-/-myctg mice, while analysis of E2-/-myctg mice 
revealed stronger collagen 1 expression. These findings were confirmed by in 
situ collagen I immunofluorescent staining. These results lead to the working 
hypothesis that cyclin E1 is a pro-fibrotic factor involved in liver fibrogenesis 
whereas cyclin E2 potentially antagonized this effect. 
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The role of E-type cyclins and G1-S phase transition in CCL4 induced 
hepatic fibrogenesis 
 
Carbon tetrachloride (CCl4) is a hepatotoxin which induces liver fibrosis 
after repetitive application at a low dose. In the liver, CCl3 radicals are formed, 
which induce hepatocytes damage and activation of hepatic stellate cells, 
leading to the production of extracellular matrix (Weiler-Normann et al., 2007). 
By using an in vivo model of CCL4-induced liver fibrosis, it was 
demonstrated in this study that depletion of cyclin E1 leads to the reduction of 
fibrosis extend. Consistently, a decrease of collagen 1 expression has been 
shown on the mRNA expression level and by in situ analysis.  In good 
correlation with these findings, the number of αSMA positive cells was 
significantly reduced in E1-/- mice compared to controls. Of notice, up-regulation 
of cyclin E1 has been found in WT mice after 4 weeks of CCL4 treatment, which 
indicates that cyclin E1 is an essential factor for the transition of hepatic cells 
through the cell cycle during fibrogenesis. All together, these findings define for 
the first time the importance of tight cell cycle regulation for liver fibrogenesis. In 
conclusion, depletion of E1 in cyclin E1-/- mice mediates the inhibitory effect on 
liver fibrogenesis in the CCl4 model. 
In contrast, after 4 weeks of CCl4 treatment E2-/- mice displayed strong 
fibrosis, revealed prominent collagen fibre formation in Sirus red staining and 
increased levels of α-SMA mRNA. Interestingly, cyclin E1 mRNA levels were 30 
times higher in E2-/- mice compared to WT animals. In summary, CCl4 treatment 
at the absence of cyclin E2 leads to prominent fibrosis similar to effects in WT 
animals. Most likely, the key player of hepatocytes cell cycle progression during 
fibrogenesis is cyclin E1. 
Liver regeneration in E2-/- mice after PH showed earlier onset of DNA 
synthesis compared to WT mice. Based on this finding, it was investigated if 
cyclin E2 depletion might also affect the onset of liver fibrosis. Therefore, a 
short term (2 weeks) CCl4 administration was performed in E2-/- mice. 
Interestingly, obvious signs of fibrosis were already found in the E2-/- group 
while in WT mice only first slight indications of fibrogenesis could be detected. 
RNA levels of αSMA and collagen 1 in E2-/- mice were also significantly higher 
compared to the WT group. These findings indicate that depletion of cyclin E2 
results in earlier, but not in stronger liver fibrogenesis after CCL4 treatment. It 
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can be speculated that during liver fibrogenesis both cyclin E1 and cyclin E2 
inversely regulate the proliferation of those hepatic cells, which are responsible 
for formation of extracellular matrix, and the most likely candidates are the 
hepatic stellate cells. 
 
In conclusion, depletion of cyclin E1 mediates inhibitory effects on liver 
fibrogenesis in the CCl4 model, while E2 is antagonizing these affects and acts 
antifibrotic.
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6. Summary 
E-type cyclins are important regulators for driving quiescent cells into the 
cell cycle. The aim of the present study was to investigate the relevance of 
cyclin E1 and E2 for directing quiescent hepatic cells into the cell cycle in vivo.  
In the partial hepatectomy (PH) model it was shown that cyclin E1-/- 
deletion results in normal liver regeneration with slight delay of G1/S-phase 
transition but absent endoreplication in hepatocytes. In contrast, cyclin E2-/- 
mice showed over-expression of cyclin E1 and prolonged cdk2 kinase activity 
leading to earlier and sustained DNA synthesis. Higher DNA synthesis in cyclin 
E2-/- mice did not result in significant more hepatocyte mitosis and proliferation, 
but was associated with higher polyploidy in the dividing hepatocytes due to 
endoreplication. Consistently, cyclin E2-/- mice showed a 45% higher liver/body 
weight ratio compared to WT animals after regeneration as a result of excessive 
polyploidization. In summary, this data suggests a new and unexpected role for 
cyclin E2 in repressing cyclin E1 function thus explaining increased S-phase 
entry and excessive endoreplication of cyclin E2-/- hepatocytes as a result of 
cyclin E1 over-expression. Moreover, this study demonstrates that cyclin E1 is 
dispensable for the onset of S-phase, but essential for endoreplication during 
liver regeneration. 
The second aim of this study was to investigate a potential contribution of 
E-type cyclins for liver fibrogenesis. In this context, over-expression of the 
proto-oncogene c-myc in murine hepatocytes was shown to serve as an 
interesting new model for liver fibrosis which is dependent on cyclin E1 and E2. 
Accordingly, alb-myctg mice are prone to spontaneous liver fibrosis which can 
be inhibited by depletion of cyclin E1, but is even enhanced with a knockout of 
cyclin E2. In the established animal model of CCl4 – induced liver fibrosis it was 
demonstrated that cyclin E1 is an essential pro-fibrotic factor, whereas Cyclin 
E2 provides inhibitory functions on the early onset of liver fibrogenesis.  
In summary, this study shows for the first time a phenotype for cyclin E1 and E2 
knockout mice and provides evidence for non-redundant, individual functions of 
both E-type cyclins during cell cycle progression and endoreplication. 
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6. Zusammenfassung 
 E-Cycline sind wichtige Zellzyklusregulatoren und steuern die Transition 
von ruhenden Zellen in die Zellzyklusprogression. Ziel der vorliegenden Arbeit 
war es, die Bedeutung der Cycline E1 und E2 für die Zellzyklusaktivierung ru-
hender Leberzellen in vivo zu untersuchen. 
Im Modell der partiellen Hepatektomie (PH) wurde gezeigt, dass eine 
Deletion von Cyclin E1 zu einer normalen Leberregeneration mit nur leicht ver-
zögertem Beginn der DNA-Synthese führt, dafür aber die Endoreplikation von 
Hepatozyten blockiert. Im Gegensatz dazu zeigten Cyclin E2-/- Mäuse eine 
Überexpression von Cyclin E1 und verlängerte cdk2 Kinaseaktivität. Dies führte 
zu einer früheren und verstärkten DNA Synthese in der Leber und resultierte in 
einem höheren Ploidiegrad der proliferierenden Hepatozyten aufgrund von 
erhöhter Endoreplikation. Daher zeigten Cyclin E2-/- Mäuse einen 45% höheren 
Leber/Körpergewichtsindex im Vergleich zu Wildtyp-Mäusen nach Leber-
regeneration. Zusammenfassend zeigen diese Daten eine neue und 
unerwartete Rolle für Cyclin E2 als negativer Regulator von Cyclin E1. Die 
gefundenen, starken Effekte in Cyclin E2-/- Mäusen (verstärkte und verlängerte 
DNA-Synthese, Hepatomegalie, exzessive Polyploidie) konnten alleine durch 
die Überexpression von Cyclin E1 in diesen Tieren erklärt werden. Darüber 
hinaus zeigt diese Arbeit, dass Cyclin E1 für die Endoreplikation in Hepatozyten 
nach Leberregeneration -, nicht aber für die Initiation der DNA-Synthese 
essentiell ist. 
Im zweiten Ziel der vorliegenden Arbeit wurde die Funktion von E-Cycli-
nen in der Leberfibrogenese untersucht. Die Überexpression des Proto-Onko-
gens c-myc in murinen Hepatozyten wurde als ein neues, Cyclin E abhängiges 
Tiermodell der Leberfibrogenese etabliert. Hepatozyten-spezifische, c-myc 
transgene Mäuse entwickeln eine Leberfibrose, die durch Ausschalten von Cyc-
lin E1 inhibiert – durch Inaktivierung von Cyclin E2 dagegen verstärkt werden 
kann. In einem etablierten Modell der CCl4-induzierten Leberfibrose wurde ge-
zeigt, dass Cyclin E1 ein essentieller, pro-fibrotischer Faktor ist, wohingegen 
Cyclin E2 inhibitorische Funktionen in der frühen Leberfibrogenese wahrnimmt. 
Zusammenfassend zeigt diese Arbeit erstmals einen Phänotyp für Cyclin 
E1 - und Cyclin E2 knockout Mäuse und weist nicht-redundante, individuelle 
Funktionen beider E-Cycline im Rahmen der Zellzyklusprogression und Endo-
replikation nach. 
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7. Appendix 
 7.1 Abbrevitions 
  
adv Adenovirus 
alb Albumin 
APS Ammoniumpersulfate 
ATP Adenosin-Triphosphat 
BSA Bovine serum albumin 
BrdU 5-bromo-2-deoxyuridine 
Cdc2 Cell division cycle 2 
CCl4 Carbon tetrachloride 
Cdk Cyclin-dependent kinases 
cDNA Copy-DNA 
dNTP Desoxy-Nukleosidtriphosphat 
DAPI 4',6-diamidino-2-phenylindole 
DNA Deoxyribonucleic Acid 
DTT Dithiotreitol 
E1-/- knock-out mice for cyclin E1 
E2-/- knock-out mice for cyclin E2 
EDTA N,N;N’,N’ Ethylendiamintetraacetat 
EGTA Ethylen glycol-bis (2-aminoethyl)- N,N;N’,N’- tetraacetate 
EGF Epidermal growth factor 
EtBr Ethidiumbromide 
FACS Fluorescent-activated cell sorter 
FISH Fluorescent in situ hybridization 
H3 Histone 3 
HE Hematoxylin Eosin 
HGF Hepatocyte growth factor 
HRP Horseradish peroxidase 
HSC Hepatic stellate cells 
H2O Water 
HEPES 2-[4-2-hydroxyethyl-1-piperazinyl]-ethansulfon acid 
GFP Green fluorescent protein 
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Ig Immunoglobulin 
IL6 Interleukin 6 
ip Intra peritoneal 
iv Intravenous 
kb Kilobasenpaare 
kDa Kilo-Dalton 
m-RNA Messenger RNA 
NaCl Natrium chloride 
MEF Mouse Embryonic Fibroblast 
NaVO3 Sodium Metavanadate 
NP40 Nonidet P – 40 
NF-κB Nuclear factor-kappa B 
PH Partial Hepatectomy 
PMSF Phenylmethylsulfonylfluorid 
OD Optical density 
PBS Phosphate buffered saline 
PCNA Proliferating Cell Nuclear Antigen 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
Rb Retinoblastoma 
RNA Ribonucleic Acid 
RT Reverse Transcription 
S-phase Synthesis phase 
SDS Sodium Dodecyl Sulfat 
αSMA alpha Smooth muscle actin 
tg Transgenic 
TBS Tris Buffered Saline 
TEMED N,N;N’,N’-Tetramethylethylendiamin 
TGF Transforming growth factor 
TNFα Tumor necrosis factor-alpha 
Tris Tris(hydroxymethyl)aminomethane 
WT Wild type 
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7.2 Publications: 
 
 Part of this work has been published in advance as scientific articles, 
scientific abstracts, posters and oral presentations as indicated below: 
Original Papers: 
 
Zschemisch, N.H., Liedtke, C., Dierssen, U., Nevzorova, Y.A., Wustefeld, T., 
Borlak, J., Manns, M.P., and Trautwein, C. (2006). Expression of a cyclin E1 
isoform in mice is correlated with the quiescent cell cycle status of hepatocytes 
in vivo. Hepatology 44, 164-173. 
 
Nevzorova, Y.A., Tschaharganeh, D., Gassler, N., Geng, Y., Weiskirchen, R., 
Sicinski, P., Trautwein, C., and Liedtke, C. (2009). Aberrant cell cycle 
progression and endoreplication in regenerating livers of mice that lack a single 
E-type cyclin. Gastroenterology 137, 691-703. 
 
Scientific Talks: 
 
Nevzorova, Y.A., Sicinski, P., Trautwein, C. and Liedtke, C. (2006). Ablation of 
cyclin E1 or cyclin E2 modifies the kinetics of liver regeneration in mice. 
Hepatology 44, 242A-242A. Talk, 56. Annual Meeting of the AASLD, Boston, 
MA, USA. 
Nevzorova, Y.A., Tschaharganeh, D.E., Sicinski, P., Trautwein, C. and Liedtke, 
C. (2007). Depletion of cyclin E2 in mice increases cell cycle activity and 
regeneration efficiency of the liver after partial hepatectomy. Journal of 
Hepatology 46, S20-S20. Talk, 41. Annual Meeting of the EASL, Barcelona, 
Spanien. 
Nevzorova, Y. A., Moro, N., Gassler, N., Sicinski, P., Trautwein, C., Liedtke, C. 
(2008).  The role of E-type cyclins and G1-S phase transition in hepatic 
fibrogenesis. J Hepatol 48, 22-22 (Suppl. 2). Talk, 42. Annual Meeting of the 
EASL, Mailand, Italien.   
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Nevzorova, Y. A., Moro, N., Gassler, N., Sicinski, P., Trautwein, C., Liedtke, C 
(2008). Depletion of cyclin E1 and E2 differentially effects the initiation and 
progression of liver fibrosis. Hepatology 48, 422A-422A Talk, 59. Annual 
Meeting of the AASLD, San Francisco, CA, USA 
 
Posters 
 
Nevzorova, Y.A., Sicinski, P., Trautwein, C. and Liedtke, C. (2007). 
Inaktivierung von Cyklin E1 oder Cyklin E2 verändert die Kinetik der 
Leberregeneration im Mausmodell. Z Gastroenterol 45, 108. Poster, 23. Annual 
Meeting of the GASL, Göttingen. 
Nevzorova, Y.A., Tschaharganeh, D.E., Moro, N., Sicinski, P., Trautwein, C. 
and Liedtke, C. (2007). The role of E-type cyclins in liver regeneration and 
fibrogenesis Z Gastroenterol. Poster, 62. Annual Meeting of the DGVS, 
Bochum. 
Nevzorova, Y.A., Tschaharganeh, D.E., Sicinski, P., Trautwein, C. and Liedtke, 
C. (2007). Differential functions of cyclin E1 and E2 for cell cycle control and 
endoreplication during liver regeneration in mice. Hepatology 46.  Poster, 58. 
Annual Meeting of the AASLD, Boston, MA, USA.  
Nevzorova, Y.A., Tschaharganeh, D. F., Moro, N., Gaßler, N., Sicinski, P., 
Trautwein, C., Liedtke, C. (2008). Absence of E-cyclins E1 and E2 affects cell 
cycle progression, fibrogenesis and tumorgenesis in the murine liver. Z 
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